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ABSTRACT 
Tissue engineering aims to find an ultimate solution for cartilage regeneration. Current 
strategies for cartilage repair using chondrocytes are limited by the usability of cell 
sources as observed in several contemporary techniques such as autologous cell 
implantations. Cartilage tissue engineering strategies involving scaffold fabrication are 
common. However, only few studies have described the use of scaffolds as a promoter 
for chondrogenic differentiation. Cartilage extracellular matrix derived scaffolds contain 
many bioactive factors that have chondrogenic potential of which if appropriately 
managed, may provide the key to successful cartilage repair outcomes. The present 
thesis describes a potential biomaterial derived from bovine articular cartilage that 
possesses chondrogenic properties, thereby being expected to promote cartilage 
regeneration. 
Bovine articular cartilage matrix derived (CMD) porous scaffolds were fabricated at 
three different concentrations (5%, 15% and 30%), through the use of freeze-drying 
method or, physically treated for cross-linking enhancement using either ultra-violet 
(UV) light or, dehydrothermal (DHT) treatment or a combination of both methods. The 
scaffolds were characterized using morphology, FESEM, FTIR, TGA, DSC, and 
porosimetry. UV and UVDHT treated 15% CMD scaffolds were found to be the best 
scaffold possessing the best possible physical properties. Human dermal fibroblast cells 
(HDF) isolated from redundant skin obtained through cosmoplastic surgery were used 
as cells for the in vitro analysis. HDF cells were cultured on UV and UVDHT treated 
15% CMD scaffolds for 42 days. Resazurin reduction test and DNA quantification 
showed an increasing cell proliferation during the first 3 weeks. GAGs production and 
the up-regulation ofSOX9, COMP, COL2A1, and ACAN genes were seenthroughout6 
weeks of cell-scaffold culture. The increase or decrease in HDF cell proliferation, 
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GAGs production and gene expression appeared correlated with the scaffold shrinkage 
and contraction patterns. 
In conclusion, bovine articular CMD porous scaffolds have the potential to induce 
chondrogenic differentiation in human dermal fibroblasts. Whilst the present thesis did 
not demonstrate the precise underlying mechanisms by which chondroinduction is 
achieved from these CMD scaffolds, it is proposed that future studies are conducted to 
investigate the involved pathways to better demonstrate the chondrogenic properties of 
this material. 
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ABSTRAK 
Kejuruteraan tisu bertujuan untuk mencari penyelesaian muktamad untuk pertumbuhan 
semula rawan. Strategi semasa untuk pembaikan tulang rawan menggunakan kondrosit 
adalah terhad dengan kebolehgunaan sumber sel seperti yang berlaku di beberapa teknik 
kontemporari seperti implantations sel autologous. Strategi kejuruteraan tisu tulang 
rawan yang melibatkan fabrikasi perancah adalah biasa. Walau bagaimanapun, hanya 
beberapa kajian telah menggambarkan penggunaan perancah sebagai penganjur bagi 
pembezaan chondrogenic. Perancah matriks extracellular tulang rawan mengandungi 
banyak faktor bioaktif yang mempunyai potensi chondrogenic jika diurus dengan baik, 
boleh menyediakan kunci kepada hasil pembaikan rawan berjaya. Tesis ini 
menerangkan biobahan potensi berasal dari tulang rawan artikular lembu yang 
mempunyai ciri-ciri chondrogenic, yang dijangka menggalakkan pertumbuhan semula 
rawan.Perancah berliang matriks tulang rawan artikular lembu (CMD) yang diperolehi 
telah direka di tiga kepekatan yang berbeza (5%, 15% dan 30%), dengan menggunakan 
kaedah beku-pengeringan atau, fizikal dirawat untuk  peningkatan hubungan silang 
sama ada menggunakan ultra-ungu (UV) atau, dehydrothermal (DHT) rawatan atau 
gabungan kedua-dua kaedah. Perancah telah dicirikan menggunakan morfologi, 
FESEM, FTIR, TGA, DSC, dan porosimetri. Perancah CMD yang dirawat dengan 15%  
UV dan UVDHT merupakan perancah terbaik yang mempunyai kemungkinan sifat-sifat 
fizikal. Sel-sel kulit fibroblast manusia (HDF) diasingkan daripada kulit berlebihan 
yang diperoleh melalui pembedahan cosmoplastic telah digunakan sebagai sel-sel dalam 
vitro analisis. Sel HDF dikulturkan di atas perancah CMD dirawat dengan 15% UV dan 
UVDHT untuk 42 hari. Pengurangan dalam ujian Resazurin dan kuantifikasi DNA 
menunjukkan percambahan sel yang semakin meningkat dalam tempoh 3 minggu 
pertama. Penghasilan GAGs dan kitaran atasan bagi gen SOX9, COMP, COL2A1, dan 
ACAN diperhatikan sepanjang 6 minggu kultur sel-perancah. Peningkatan atau 
vi 
pengurangan dalam percambahan sel HDF, penghasilan GAGs dan eksperasi gen yang 
muncul dikaitkan dengan pengecutan perancah dan corak pengecutan. 
Kesimpulannya, perancah berliang artikular lembu CMD mempunyai potensi untuk 
mendorong pembezaan chondrogenic dalam fibroblas kulit manusia. Manakala tesis ini 
tidak menunjukkan mekanisme yang tepat tentang chondroinduction yang dicapai 
daripada ini perancah CMD, adalah dicadangkan bahawa kajian masa depan perlu 
dijalankan untuk menyiasat laluan yang terlibat supaya lebih sifat chondrogenic bahan 
ini dapat ditunjukkan. 
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CHAPTER 1: INTRODUCTION 
1.1 Introduction 
For the past three centuries, it is commonly accepted that cartilage damage results in 
poor healing. As described by Hunter, "If we consult the standard Chirurgical Writers 
from Hippocrates down to the present Age, we shall find, that an ulcerated Cartilage is 
universally allowed to be a very troublesome Disease; that it admits of a Cure with more 
difficulty than carious Bone; and that, when destroyed, it is not recovered" (Hunter, 
1809). Articular cartilage has limited healing capacity following an injury due to low 
mitotic activity and limited supply of cells (chondrocytes). In addition, the absence of 
vascular supply and blood perfusion, and limited mobility of chondrocytes to the 
damaged sites further adds to this insult(Buckwalter & Mankin, 1997; Curl et al., 1997; 
Kasemkijwattana, Kesprayura, & Chanlalit, 2009; McPherson & Tubo; Shelbourne, 
Jari, & Gray, 2003). Over the last few decades, physicians and scientists have been 
working hard to find several different strategies to repair damaged articular cartilage. 
The target has always been to restore the damaged hyaline cartilage to its original 
condition. In the past several different procedures have been suggested, however they 
have been less attractive due to the limited repair outcomes. Arthroscopic lavage and 
debridement(Finkelstein & Mayer, 1931), marrow stimulation techniques(Pridie, 1959), 
osteochondral grafts(Hangody & Fules, 2003; Hangody, Kish, Karpati, Szerb, & 
Udvarhelyi, 1997; Hangody et al., 2004; Jacobs, 1965; Lane, Brighton, Ottens, & 
Lipton, 1977), and autologous chondrocyte implantation(Peterson, Minas, Brittberg, & 
Lindahl, 2003) have been the main surgical procedures described, however none has 
proved to be the ultimate solution for cartilage regeneration.  
Tissue engineering repair strategies such as the use of organized delivery of suspended 
cells by means of scaffold constructs can fill in the voids within cartilage defects. This 
provides a superior alternative to routine surgical interventions, which has been shown 
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to produce good mid-term outcomes. To engineer cartilage one must consider the need 
to fulfil all three prerequisites of the tissue engineering triad: the cells which will 
function just like chondrocytes, the appropriate extracellular matrix which provides the 
signalling factors, and the appropriate tissue micro-architecture that recreates the natural 
state of the cartilage microenvironment. 
Tissue engineering solutions for cartilage repair using chondrocytes are limited by the 
low number of available chondrocytes. This is mainly due to the limited available 
sources that are required for this treatment. Moreover, additional procedure is needed to 
retrieve cartilage from a donor region of the patient. In addition, we need to be mindful 
that allogeneic chondrocytes may not be the most suitable cell of choices due to the 
immune responses it elicits following transplantation(Hyc, Malejczyk, Osiecka, & 
Moskalewski, 1997; Kyriacos A. Athanasiou, 2013; Moskalewski, Hyc, & Osiecka‐
Iwan, 2002).Tissue engineered adult cells have been said to possess chondrogenic 
differentiation potential. However, harvesting these chondroprogenitors is usually no 
easy task. Chondroprogenitor cells can be isolated from bone marrow (Longobardi et 
al., 2006), synovium (Nishimura et al., 1999; Shirasawa et al., 2006), fat (Erickson et 
al., 2002), and skin (Sommar, 2010) and be used for cartilage tissue engineering 
(Johnstone, Yoo, & Stewart, 2008). 
Different natural (collagen, fibrin, chitosan, hyaluronic acid, alginate gels, agarose, 
silks, and etc.) and synthetic (PLA-PGA, polyurethanes, polycarbonates, polyfumarates, 
PEGT-PBT block copolymers, etc.) biodegradable polymers have been used for scaffold 
fabrication for cartilage tissue engineering. Extracellular matrix components can be 
included during the fabrication of the scaffold (Mahmoudifar & Doran, 2012). The ideal 
biomaterials for tissue engineering are supposed to be biocompatible and non-toxic. In 
addition, they must provide good cell adhesion site, possess high porosity for good cell 
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penetration, allow nutrient exchange to occur, and are bioresorbable. The biomaterial 
must also provide a framework that allows proper mechanical properties for migration 
and proliferation of seeded cells. This in turn allows early weight bearing to occur. A 
tailored surface chemistry can enhance appropriate cellular responses in order to 
maintain or promote their phenotypic expression. The scaffold design is also important 
to assist in the formation of the desired tissue. This can be achieved by using cell culture 
systems to generate fully functional tissues that support production of ECM components 
to mimic the biochemical and mechanical properties of native articular cartilage as 
closely as possible. 
1.2 Problem statement 
Typical approaches of cartilage tissue engineering have included the seeding of 
chondrocytes or chondroinducible cells on custom made scaffolds that can simulate 
chondrocyte to thrive as if these cells live within their native environment. Different 
hydrogel and porous scaffolds composed of synthetic and/or natural materials have been 
fabricated previously with the intentions to mimic cartilage extracellular matrix. While 
different methods have been applied to fabricate biocompatible scaffolds that can 
support cartilage matrix production, none of the scaffolds has shown to be ideal for 
cartilage tissue engineering especially when considering these materials lack in the 
ability to initiate any chondrogenic effects. Therefore, a study was conducted using a 
novel biomaterial and an unconventional source of cell to demonstrate a superior 
outcome based on our hypothesis that a good biomaterial using acceptable and more 
abundant cell source may be adequate for the requirements needed for successful 
cartilage repair to occur. In the present thesis, a potential biomaterial derived from 
bovine articular cartilage matrix to induce chondrogenesis in human dermal fibroblasts 
as potential chondroinducible cells are described and discussed. 
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1.3 Objectives 
i. Fabrication, characterization, and optimization of bovine articular cartilage 
matrix derived porous scaffold. 
ii. Isolation, culture and characterization of Human Dermal Fibroblast cells. 
iii. Investigation of the chondrogenic effects of bovine articular cartilage matrix 
derived porous scaffold on human dermal fibroblast cells in 3D culture. 
1.4 Thesis layout 
This thesis consists of six chapters. Following the introduction, the second chapter 
critically reviews the relevance of this study within the current literature. The third 
section will disclose the underlying theory and the experimental steps involved in the 
fabrication, characterization and optimization of bovine articular cartilage matrix-
derived porous scaffolds. Chapter four outlines the procedures that lead to the isolation, 
culture and characterization of human dermal fibroblasts (HDFs). The fifth chapter 
discusses the methodology and rationales of assessment of chondrogenic effects of 
bovine articular cartilage matrix-derived porous scaffolds on HDF cells. Finally, the 
sixth chapter provides the discussion, conclusion and the suggestions for future works 
of the present thesis. 
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CHAPTER 2: LITERATURE REVIEW 
2.1 Introduction 
Cell-based therapies in cartilage tissue engineering take advantage of highly porous 
interconnected three dimensional scaffolds that can provide enough surface area and 
space for cell attachment, proliferation, extracellular matrix production and deposition 
to occur; which also includes nutrient and waste exchange. Apart from selecting suitable 
cells and growth factors, the use of proper scaffolds with appropriate physiochemical 
structure (Pramanik, Pingguan-Murphy, & Abu-Osman, 2012) will favour cellular 
biocompatibility and adhesion/proliferation. The scaffolds must possess suitable 
geometry and mechanical properties (Hutmacher, 2000), has to be highly porous and 
have interconnectivity between areas, possess stability and consistency in its mechanical 
strength, and a proper surface micro-morphology that will support cellular 
differentiation(Pramanik et al., 2012). Different three-dimensional (3D) constructs such 
as complex branched helical microchannels of microfluidic hydrogels may provide good 
network structures (G. Huang et al., 2013). Various types of hydrogels, polymers, 
scaffolds and composites of different materials that can support cartilage matrix 
production have been previously described. (Hutmacher, 2000; Lu, Zhu, Valenzuela, 
Currier, & Yaszemski, 2001; Moradi, Dalilottojari, Pingguan-Murphy, & Djordjevic, 
2013; Moutos & Guilak, 2008). The material from which the scaffold is fabricated plays 
a key role in chondroinduction. It has been suggested that modified native extracellular 
matrix (ECM) may contain bioactive factors that can contribute to cell growth, 
migration, and differentiation. Different constructs that incorporates bone and cartilage 
matrix components have been tested for their chondrogenic effects previously. In 
addition, demineralized bone implants have been used for certain reconstructive 
procedures since before 1985 (J Glowacki & Mulliken, 1985).Other studies have also 
described the use of bilayer collagen porous constructs which sandwiches demineralized 
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bone particles, which demonstrated positive chondroinductive effects on human dermal 
fibroblasts (J Glowacki, 1996; J Glowacki & Mizuno, 1997; J Glowacki, Yates, Little, 
& Mizuno, 1998; S Mizuno & J Glowacki, 1996; Shuichi Mizuno & Julie Glowacki, 
1996; Shuichi Mizuno, Lycette, Quinto, & Glowacki, 1992). However the issue of 
ossification formation was observation in these constructs. In general, the closer the 
material is to cartilage native matrix the higher the probability of achieving a suitable 
engineered cartilage. For this reason, pure cartilage matrix derived (CMD) scaffolds 
have recently been suggested as a viable alternative. 3D culture of chondroinducible 
cells on cartilage matrix components seems logical, as they are expected to provide 
structural and biochemical signals at the same time (Murphy, Haugh, & O'Brien, 2010; 
Rowland, Lennon, Caplan, & Guilak, 2013; Q. Yang, Peng, Guo, Huang, Zhang, Yang, 
et al., 2008; Z. Yang et al., 2009).Human (Q. Yang, Peng, Guo, Huang, Zhang, Yao, et 
al., 2008) and porcine (Cheng, Estes, Awad, & Guilak, 2009) articular cartilage ECM 
derived scaffolds have been fabricated and shown promising results with human adipose 
derived adult stem cells and canine bone marrow stem cells respectively, supporting the 
hypothesis that a scaffold derived absolutely from cartilage ECM can induce 
chondrogenesis. 
To better understand the nature of cartilage ECM derived scaffolds a brief description of 
cartilage matrix composition will be described in the subsequent sub-chapters. 
2.2 Biochemical Composition of Articular Cartilage 
Human cartilage is a semi-solid jelly-like connective tissue which is derived from 
embryonic mesenchyme. It has four classifications based on the matrix composition: 
fibro cartilage, elastic cartilage, fibro-elastic cartilage, and hyaline cartilage. The 
hyaline cartilage which is bluish white when unstained is mainly seen at the diarthrodial 
joints covering long bones and also forming the growth plates during the longitudinal 
growth age. Articular cartilage which is composed of hyaline cartilage acts as a low-
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friction wear-resistant gliding surface by means of its high compressive strength 
(Buckwalter & Mankin, 1997). Like all other connective tissues, the hyperhydrated 
articular cartilage consists of cells and matrix. Extracellular matrix of the articular 
cartilage consists of water and solids. The precise biochemical composition of the 
extracellular matrix of the articular cartilage is depicted in the Table  2.2.  
Table ‎2-1: Biochemical composition of articular cartilage. 
CONSTITUENT VALUE BY WEIGHT 
Water 66% - 79% 
Solids 21% - 34% 
Inorganic  
Ash 5% - 6% 
Organic  
Collagen 48% - 62% 
Protein 8% - 15% 
Glycosaminoglycan 14% - 23% 
Hyaluronate < 1% 
Lipid < 1% 
Lysozyme < 1% 
Glycoprotein ? 
 
2.2.1 Water 
Intracellular and intercellular water account for 65-80% of the articular cartilage wet 
weight with differences in distribution in superficial and deep zones (Bhosale & 
Richardson, 2008). The degree of hydration varies with age and species (McDevitt, 
1973). The water-macromolecules interaction within the matrix determines the 
mechanical properties of the articular cartilage tissue(Hunziker, 1990). 
8 
2.2.2 Collagens 
Collagen forms 10-20% of wet weight(Bhosale & Richardson, 2008), i.e. 60% of the 
dry weight of adult  articular cartilage(McDevitt, 1973). It also forms the endoskeleton 
of cartilage (Huber, Trattnig, & Lintner, 2000). The most abundant form of collagen and 
the principal component of the macrofibrilar framework is type II collagen (90–95%) 
which is seen as a macrofibrilar framework within cartilage tissue, and is responsible for 
providing the tensile strength of the articular cartilage (Bhosale & Richardson, 2008). 
2.2.3 Proteoglycans 
Proteoglycans are heavily glycosylated glycoprotein molecules consisting of core 
proteins with covalently attached negatively charged long linear glycosaminoglycan 
(GAG) chains produced inside the chondrocytes and secreted into the cartilage matrix 
(McDevitt, 1973). Proteoglycans form 10-20% of wet weight of the articular cartilage. 
They are the filler substances existing between cells forming large complexes, both to 
other proteoglycans and also to collagen molecules providing the compressive strength 
of the articular cartilage. They are also involved in binding cations (such as sodium, 
potassium and calcium) and water; creating a Donnan effect and regulating the 
movement of fluid and electrolytes through the matrix(Aichroth, Burwell, & Laurence, 
1972). 
2.3 Rationale of Current Study 
Considering the current limitations of cartilage tissue engineering strategies, this thesis 
is focussed in the development of a biomaterial scaffold derived from bovine articular 
cartilage extracellular matrix that would promote chondrogenic differentiation of 
chondroinducible cells and hence providing evidence to the potential development of 
tissue engineered constructs that closely mimic native articular cartilage.  
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The source from which the matrix is derived is a major concern. Human sources are 
impractical due to lack of supplies and the ethical issues related to their procurement. 
Porcine derived products also have limitations mainly due to religious ethical 
considerations. More so for a country such as Malaysia where over 60% of the 
population are predominantly Muslims. Animal sources with high abundance but 
without ethical issues can be solution of choice. 
Preserving the integrity of native cartilage ECM components is a key factor in taking 
advantage of the total capacity of bioactive factors responsible for chondrogenesis. 
Therefore non-invasive fabrication methods must be considered when developing this 
material. 
The weak mechanical properties of absolute ECM derived scaffolds accounts for the 
majority of the disadvantages that arise, especially after seeding the cells. It has been 
mentioned previously that the tendency of scaffold shrinkage and contraction can be an 
issue as the result of this. This limits the ability of the scaffold to induce and enhance 
chondrogenic differentiation of non-chondrocytic cells.  
Finally, for cartilage tissue engineering purposes, the scaffold is expected to support the 
maintenance of chondrocytes or differentiation of other cells with chondrogenic 
potential. Maintenance of the chondrocyte phenotype is especially important for 
cartilage tissue engineering, as chondrocytes are particularly quick to lose their 
phenotype during the expansion process in vitro. 
All in all, to help alleviate the above-mentioned issues, four major concerns with 
cartilage matrix derived scaffolds need to be addressed: 
 The source of cartilage harvesting is supposed to be large quantity, easy to 
access and must be cost-effective. 
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 The fabrication method is to be non-invasive to and extent that the bioactive 
components within the cartilage matrix are not loss or damaged. 
 Proper fabrication and treatment strategies must be applied to improve the 
physical architecture and enhance the mechanical properties of the scaffolds. 
 Chondrogenic potentials of the scaffolds must be proved through in vitro 
studies using chondroinducible cells. 
Hence, the scaffolds need to be tailored from an abundant, cost-effective, and an 
ethically acceptable source. The fabrication procedures will not cause significant 
degradation in ECM components while providing a proper architecture that allows the 
cells to penetrate deep into the core of the scaffold, attach, proliferate and exert 
chondrogenic differentiation. In this study, bovine articular cartilage was focussed as 
the potential source of cartilage matrix harvesting for tissue engineering applications 
since it fulfils all of the mentioned criteria. 
2.4 Bovine Articular Cartilage: A Potential Source of Cartilage Matrix 
Articular cartilage with animal source has drawn attention in tissue engineering due to 
its abundance. Considering that the world cattle population is estimated to be over 1.4 
billion animals(Yearbook, 2012), bovine cartilage is a vast potential source of 
inexpensive matrix acquisition.  
Viscoelastic and mechanical properties (Charlebois, McKee, & Buschmann, 2004; 
Fulcher, Hukins, & Shepherd, 2009; S. Park, Hung, & Ateshian, 2004), the structure of 
high density proteoglycans (Hunter, 1809), and the three dimensional collagen 
architecture (Jeffery, Blunn, Archer, & Bentley, 1991) in bovine articular cartilage have 
already been investigated. However, the suitability of bovine articular cartilage matrix 
in fabrication of scaffolds with chondroinductive effects remains undetermined. 
Abundance, inexpensiveness and lack of religious ethical issues (unlike porcine, canine 
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and murine) are the advantages of tailoring scaffolds derived from bovine articular 
cartilage for tissue engineering applications. 
2.5 Enhancing Mechanical Properties 
Achieving a mechanical strength similar to that of native articular cartilage is vital to the 
success of cartilage tissue engineered constructs, as one of the primary functions of the 
tissue in vivo is to provide mechanical support. Although CMD scaffolds provide 
numerous advantages for cartilage tissue engineering, it has been proven that the they 
provide weak resistance to compressive forces(Diekman, Rowland, Lennon, Caplan, & 
Guilak, 2009), leading to cell mediated contraction and shrinkage of the construct 
(Zaleskas et al., 2004). As a result, the cells within the construct will have less access to 
the diffused nutrients and less room for multiplication and matrix production (C. Lee, 
Grodzinsky, & Spector, 2001). For this reason, various techniques have been developed 
to improve one or both aspects. 
Mechanical properties, resorption kinetics, and biocompatibility of collagen-based 
biomaterials can be influenced by cross-linking methods(Bellincampi & Dunn, 1997; L. 
Damink et al., 1995).Different methods of chemical and physical cross-linking 
treatments have been used extensively to enhance the physio-mechanical and 
immunogenic properties of matrix derived constructs(Bellamkonda, Ranieri, Bouche, & 
Aebischer, 1995).  
2.5.1 Chemical cross-linking 
Chemical cross-linking of collagen fibres in animal hides is an established technique to 
increase their resistance against decomposition. Collagen is the most abundant matrix 
protein in the animal kingdom (Lodish et al., 2000). For medical applications, chemical 
cross-linking is done to decrease collagen degradation through the use of proteinases as 
well as minimizing immunogenicity of xenografts (Ratner, 2004). Several chemical 
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cross-linkers have been used in fabrication of biologic grafts and include 
glutaraldehyde(L. O. Damink et al., 1995), hexamethylene diisocyanate 
(HDI)(Mendoza-Novelo, Mata-Mata, Vega-González, Cauich-Rodríguez, & Marcos-
Fernández, 2014), 1-Ethyl-3-(3dimethylaminopropyl)carbodiimide (EDC, EDAC or 
EDCI)(J. Lee, Edwards, Pereira, & Samii, 1996). However, chemical cross-linking 
causes changes in the molecular architecture of the constructs and therefore can 
decrease cell growth significantly (S. J. Huang & Edelman, 1995; Jarman-Smith et al., 
2004; Kimuli, Eardley, & Southgate, 2004). 
2.5.2 Physical cross-linking 
Physical cross-linking methods have also been applied during the development of 
matrix derived constructs to enhance their mechanical properties(Charulatha & 
Rajaram, 2003; Weadock, Miller, Bellincampi, Zawadsky, & Dunn, 1995; Kevin S 
Weadock, Edward J Miller, Eric L Keuffel, & Michael G Dunn, 1996).Physical cross-
linking strategies such as ultra violet (UV) light and dehydrothermal (DHT) treatment 
for cartilage matrix components have been found to enhance mechanical properties 
(Haugh, Jaasma, & O'Brien, 2009), although contradictory findings have been reported 
with the use of chemicals. Carbodiimide treatment was reported to retain the original 
dimensions of CMD scaffolds (Rowland et al., 2013). However, the use of 
glutaraldehyde treatment results in higher stiffing effects as compared to DHT treatment 
(Haugh, Murphy, McKiernan, Altenbuchner, & O'Brien, 2011). Nevertheless, the stiffer 
carbodiimide or glutaraldehyde treated CMD scaffolds showed higher cell attachment, 
proliferation and migration with perosteoblast cells compared to DHT treated scaffolds 
(Haugh et al., 2011) while inhibition of cell attachment and alterations in newly 
synthesized matrix composition in MSCs seeded on carbodiimide treated CMD 
scaffolds were reported in another study (Rowland et al., 2013). 
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Considering the disadvantages of chemical cross-linking, in this study we remained 
focussed on physical treatments: ultra-violet (UV) irradiation, dehydrothermal (DHT) 
treatment, and combinations of them. 
2.6 Human Skin: A potential source of cells (Fibroblasts) 
Scaffolds and hydrogels are mainly composed of type II collagen. It has been due to this 
that these materials have been shown to induce and support the differentiation of 
mesenchymal stem cells both in vitro and in vivo; with and without the addition of 
growth factors. Many studies have also demonstrated that culturing stem cells in an 
environment similar to that of in vivo cartilage can promote and support 
chondrogenesis.  
Three-dimensional culture of cells for tissue engineering necessitates the seeding of 
high densities of cells i.e. 10
6
-10
8
 cell*ml-1 on 3D construct(Buckley, Thorpe, O'Brien, 
Robinson, & Kelly, 2009; C.Y. Charles Huang, P.M. Reuben, G. D'Ippolito, P.C. 
Schiller, & H.S. Cheung, 2004; R. Mauck, C.-B. Wang, E. Oswald, G. Ateshian, & C. 
Hung, 2003a). This high number of cells must either be isolated in large quantities or 
subcultured to reach these numbers. Therefore the cells with easy isolation and rapid 
proliferation would be the source of choice. While harvesting stem cells from bone 
marrow and through liposuction are said to be minimally invasive, other more readily 
available and much easier to extract are presently available. The skin, which has an 
average surface area of 1.5-2 m
2
 in adult, is one such source. 
One issue that needs to be highlighted is that culture of chondrocytes in monolayer 
yields fibroblastic cells, which may not be ideal to produce cartilaginous repair(Kim, 
Cho, Hong, Rhie, & Yoon, 2008). It has been demonstrated that aggrecan-sensitive sub-
populations of cells isolated from goat dermis demonstrated multi-lineage 
differentiation potential. These cells were referred to dermis-isolated adult stem cells 
14 
(DIAS) have been reported to possess chondrogenic potential (Deng, Hu, & Athanasiou, 
2007; Sanchez-Adams & Athanasiou, 2012).  What is interesting to note is that it has 
been shown that some variations of fibroblastic cell lines may be induced to 
differentiate into various directions (French, Rose, Canseco, & Athanasiou, 2004; 
Sommar, 2010). Monolayer culture of rabbit dermal fibroblast cell line, pre-treated with 
IGF-I on aggrecan coated plates have been reported to induce chondrocytic 
differentiation (French et al., 2004).  Human foreskin dermal fibroblasts seeded on 
collagen/demineralized bone powder constructs have shown chondrogenic 
differentiation (J Glowacki, 2000; J Glowacki & Mizuno, 1997; J Glowacki et al., 1998; 
J Glowacki, Zhou, & Mizuno, 2009; S Mizuno & J Glowacki, 1996; Shuichi Mizuno & 
Julie Glowacki, 1996; S Mizuno & Glowacki, 2005; Shuichi Mizuno et al., 1992; Yates 
& Glowacki, 2003; Zhou, Yates, Eid, & Glowacki, 2005). 
Fibroblast growth factors (FGFs) are a family of growth factors involved in many 
signalling pathways and the developmental processes of cells(Powers, McLeskey, & 
Wellstein, 2000; Thisse & Thisse, 2005). Fibroblast growth factor-18 (FGF-18) and 
Fibroblast growth factor-2 (FGF-2) have been shown to have chondroinductive effects 
during cartilage repair (Chiou, Xu, & Longaker, 2006; Liu, Xu, Colvin, & Ornitz, 2002; 
Moore et al., 2005). Fibroblast can be cultivated from embryonic and adult tissues, and 
they also are able to differentiate into chondrocytes that are cells of mesenchymal 
origin.  
The environment by which cells are cultured is one of the most important of the 
determining factors in the differentiation of cultured cells. The use of three-dimensional 
culture of fibroblasts is not enough on its own to produce chondrocytes. Culture of 
murine embryonic fibroblast cells on perlecan (an ECM cross-linker protein) has been 
shown to produce massive formation of cartilaginous nodules and expression of 
chondrocyte markers such as collagen II (COLII), aggrecan (ACAN) and perlecan 
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(PLC) (French et al., 1999). In addition, the culture of rabbit dermal fibroblast cell lines 
on aggrecan can lead to the formation of dense cellular aggregates rich in cartilage 
matrix components (French et al., 2004).  
It is possible that the forced expression of several reprogramming factors (Klf4 and c-
Myc) and one chondrogenic factor (SOX9) can be achieved through the induction of 
chondrogenic cells from mouse skin fibroblasts (Hiramatsu et al., 2011; Outani et al., 
2013). 
Clonal analysis of human dermal fibroblasts isolated from foreskin using standard 
dermal fibroblast culture system showed that fractions of these cells are unipotent and to 
certain extent, bipotential(Chen et al., 2007). In all, dermal fibroblasts are no longer 
assumed to be terminally differentiated cells and hence can possess differentiation 
capabilities. 
The excision of dermal tissue for the isolation of fibroblastic cells is much less invasive 
than the removal of cartilage. The donor site will usually heal without any complication 
or resulting from chronic pain. It is preferable that non-sun-exposed areas of the skin 
like the anterior aspect of thighs and buttock area used for partial thickness graft 
procedure. For full thickness grafts, skin at the groin is the most commonly used as a 
donor site. Cubital and postauricular areas are also considered good areas for harvest 
since they leave minimal scars at the donor sites. However, the size available for harvest 
is limited and there is a risk for wound infection. It is therefore important that tissues 
which are aseptically handled which remains undamaged and unexposed to sunlight 
areas such as the axilla, groin or foreskin are chosen for these reasons. Using Neonatal 
Foreskin Fibroblasts from newly circumcised Infants is an easy way of obtaining skin 
tissue(French, Liu, & Athanasiou, 2002). The human foreskin is a very good potential 
source of cells since many communities around the world practice of circumcision 
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regularly as part of their culture and religious practices(WHO/UNAIDS, 2007). It is 
worth noting that the use of the preputial foreskin as an alternative donor site is not a 
new idea. In any hospital, having an active maternity or paediatric surgery service, one 
may obtain all the foreskins necessary. Redundant skin and leftovers from cosmoplastic 
surgeries that are otherwise usually discarded can also be used for tissue engineering 
applications. 
 
In this study, scaffolds composed of decellularized bovine articular cartilage were 
fabricated, characterized and optimized by different concentrations and physical 
treatments. The tissue engineering and chondrogenic potential of two of the optimized 
scaffold was then tested by seeding the scaffolds with human dermal fibroblasts and 
evaluating the properties of the constructs and the cells after long-term static culture.   
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CHAPTER 3: FABRICATION, CHARACTERIZATION AND 
OPTIMIZATION OF CMD SCAFFOLDS 
3.1 Introduction 
Attempts to repair and regenerate damaged cartilage through cartilage tissue 
engineering have failed to meet the needs of most patients. Despite this, tissue 
engineering techniques using multi-pronged strategies are still promising approaches to 
solve this problem. Apart from the difficulties in having suitable cells and growth 
factors, the use of a proper scaffold with appropriate physiochemical structure 
(Pramanik et al., 2012) that is biocompatible and improves cell adhesion/proliferation 
appears limited. Scaffolds must not only possess suitable geometry and mechanical 
properties (Hutmacher, 2000), but also need to demonstrate high porosity and 
interconnectivity, stability and consistency of mechanical strength, and a proper surface 
micro-morphology (Pramanik et al., 2012). Different three-dimensional (3D) constructs 
such as complex branched helical microchannels of microfluidic hydrogels can provide 
good network structures (G. Huang et al., 2013). The material from which the scaffold 
is fabricated plays a key role in chondroinduction. Various types of hydrogels, 
polymers, scaffolds and composites of different materials that can support cartilage 
matrix production have been described. (Hutmacher, 2000; Lu et al., 2001; Moradi et 
al., 2013; Moutos & Guilak, 2008). It has been suggested that by modifying native 
extracellular matrix (ECM) that contains bioactive factors which promotes cell growth, 
migration, and differentiation can be expected. In general, the closer the material is to 
cartilage native matrix the higher the probability of it becoming a suitable engineered 
cartilage. For this reason, cartilage matrix derived (CMD) scaffolds have recently drawn 
the attention of many researchers. This is especially so since 3D culture of 
chondroinducable cells on CMD components appears to provide structural and 
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biochemical signals at the same time(Murphy et al., 2010; Rowland et al., 2013; Q. 
Yang, Peng, Guo, Huang, Zhang, Yang, et al., 2008; Z. Yang et al., 2009). 
Although CMD scaffolds provide numerous advantages for cartilage tissue engineering, 
it has been shown that they have a weak resistance to compressive loading (Diekman et 
al., 2009), leading to cell mediated contraction and shrinkage of the construct (Zaleskas 
et al., 2004). As a result, the cells within the construct will have less access to the 
diffused nutrients and less room for multiplication or matrix production (C. Lee et al., 
2001). In order to improve the mechanical properties, physical cross-linking strategies 
such as ultra violet (UV) light and dehydrothermal (DHT) treatment are normally 
recommended (Haugh, Jaasma, et al., 2009). Nevertheless this does not always appear 
to produce good results. Contradictory findings have been reported with the use of 
chemical methods. Carbodiimide treatment was reported to retain the original 
dimensions of CMD scaffolds (Rowland et al., 2013). However glutaraldehyde 
treatment results in higher stiffness as compared to DHT treatment (Haugh et al., 2011). 
It has been demonstrated that the stiffer carbodiimide or glutaraldehyde treated CMD 
scaffolds showed higher cell attachment, proliferation and migration with preosteoblast 
cells compared to DHT treated scaffolds (Haugh et al., 2011) while a different study 
showed that culture of MSCs on carbodiimide treated CMD scaffolds resulted in 
inhibition of cell attachment and alterations in newly synthesized matrix 
composition(Rowland et al., 2013).  
Scaffolds for cartilage tissue engineering are typically polymeric/biopolymeric three-
dimensional constructs meant to provide temporary physical, mechanical and biological 
support for the chondrocytes and chondroinducible cells (Izadifar, Chen, & Kulyk, 
2012). The main aim of this chapter is to present the methodology of fabrication, 
treatment and optimization of bovine articular CMD porous scaffolds for cartilage tissue 
engineering applications. In this chapter, our study describes that how the physical 
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structure of the CMD scaffolds is used as the main criteria for scaffold selection. Gross 
morphology, pore size, porosity, and mechanical properties of the scaffolds will be 
studied through different tests. Thermodynamic properties, infrared spectroscopy data 
will be used as complementary tests for further characterization and additional 
supportive data to rationalize the architectural characteristics of the scaffolds. 
3.2 Materials and Methods 
3.2.1 Cartilage Matrix Derived (CMD) Scaffold Preparation 
Bovine articular cartilage (BAC) was excised from both proximal and distal surfaces of 
metacarpophalangeal joints of calf hooves procured from a local slaughter house 
(Figure 3-1).  
 
Figure ‎3-1: A) lengthwise incision along the cannon bone down to metacarpophalangeal joint, 
B&C) Peeling the skin off, D) Opening the joint, E) Shaving the cartilage from bone, F) De-
cartilaged bone with shaved cartilage flakes in the container. 
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BAC tissues from 9 cow legs were lyophilized (FreeZone, Lanconco, USA) after 
weighing. The dry weights were measured using an electronic balance with a resolution 
of ±0.0005g (SHIMADZU AY220 Analytical Balance). 
The rest of the cartilage tissue was pooled, minced, shattered and homogenized using a 
BIOSPEC Tissue TEAROR
TM
 (#985370-395) in 1 X phosphate buffered saline (PBS), 
5 mMethylenediaminetetraacetic acid (EDTA) and 0.15 mMphenylmethylsulfonyl 
fluoride (PMSF) buffer solution at pH 7.4.The resulting slurry was centrifuged at 2000 
rpm for 5 min, and the collected supernatant was further centrifuged at 6000 rpm for 5 
min. The tissue slurry was decellularized in 1% TritonX-100 (Fisher Scientific) 
prepared in 0.01M Tris-HCl (Sigma # T5941) and left in a 4°C fridge while gentle 
agitation was applied for 12 h.  After 12 h, the decellularized slurry was centrifuged at 
6000 rpm for 5 min, washed with PBS, and incubated for 12h at 37°C in a hybridization 
oven with a low rotating speed in 50U.ml
-1
DNAse I (Sigma # DN25) and 10 mM 
TrisHCl (Sigma # 88438). Finally, the slurry was washed twice with PBS and 
centrifuged at 6000 rpm for 5 min. 
The scaffolds were produced by mixing the decellularized slurries with ultrapure water 
(UPW; conductivity = 0.055 ľS/cm at 25 °C, total organic carbon value < 1 ppb; 
membrapure Aquinity, Scientech, Taiwan) and placed in cylindrical Teflon molds at 3 
mm depth and 7 mm diameter.  Scaffolds were prepared at 5%, 15% and 30%(w/v) 
concentrations, frozen at a constant temperature of -80ºC for 2 hours in a freezer, then 
freeze-dried at -50ºC, 0.04 millibar for 16 hours with no additional annealing steps, and 
post treated by:  (A) no treatment (control), (B) exposed to ultraviolet light at an energy 
concentration of 8 J/cm
2  
for 90min for each side (λ =254 nm) (henceforth‘UV’), (C) 
dehydrothermal treatment which means  heating the scaffolds in a forced-air convection 
oven (Lab Companion OF-11E, China)at 120°C for 24 h (henceforth as ‘DHT’), (D) 
UV follow by DHT treatment (‘UVDHT’), and E) DHT treatment  followed by  UV 
21 
treatment (‘DHTUV’). Although all dry scaffolds will be 100% composed of cartilage 
matrix, codes of the scaffolds are named as 5%, 15% and 30% CMD scaffolds based on 
the preparation concentration. 
 
Figure ‎3-2: Fabrication process of CMD scaffolds consists of the following steps: (A&B) mincing 
and shattering the cartilage flakes, (C) homogenization in PBS-EDTA-PMSF solution, (D) yielding 
the slurry after several wash/centrifugation steps, and (E&F) dispensing the diluted slurry into the 
holes of the Teflon mold. 
 
3.2.2 Characterization of CMD Scaffolds 
3.2.2.1 CMD scaffold macro and micro morphologies 
A digital camera (Canon PowerShot A570 IS) was used to capture cross-sectional 
images of the top view of the CMD scaffolds. ImageJ®, version 1.47v software was 
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used for cross-sectional surface area (As) measurement. Percentage of shrinkage was 
calculated using Eq.1 for each type of scaffold with respect to the constant circular area 
of the mold (Am) with a diameter of 7 mm.  
% Shrinkage =
A𝑠
A𝑚
100   ... ... (Eq. 1) 
3.2.2.2 Field emission scanning electron microscopy (FESEM) 
A field emission scanning electron microscope (FESEM) (Quanta
TM
 250 FEG – FEI) 
was used to assess micro-morphology, pore size, and pore distribution. All scaffolds 
were gold coated (at a thickness of around 450 Å) using a 150 rotary-pumped sputter 
coater (Quorum Technologies). ImageJ® software was used to calculate the pore sizes. 
Colour thresholding in ImageJ® facilitates the detection of pore borders and enhances 
measurement accuracy. FESEM images of n=3 samples from each group of scaffolds at 
a magnification of 100 x were used for pore size measurement. Since all the identical 
samples from each concentration and treatment were uniform, the data of a 
representative scaffold from each group were analysed for pore size measurement. Each 
image was divided into 9 virtual equal squares. Measurements were done randomly 
from 3 of the squares. For each sample n ≥50 bidirectional pore diameters were 
measured. The mean pore diameter was calculated from the average of maximum and 
minimum diameters of a pore. 
3.2.2.3 Porosity measurement 
Scaffold porosity was measured using microvolumetric modification of the liquid 
displacement method based on a novel method developed by the author to meet the 
requirements of this study, and detailed at length in the following chapter (Moradi, 
Pramanik, Ataollahi, Kamarul, & Pingguan-Murphy, 2014). Briefly, changes in hexane 
level in a glass pipette after immersing (V1) and removing (V2) of each scaffold 
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(n≥11for each type of scaffold) were recorded by a digital camera and analysed by 
ImageJ® software. The percentage pore volume was calculated using Eq. 2:  
Total pore volume =
V2
V1+V2
100  … … (Eq. 2) 
3.2.2.4 Thermogravimetric analysis (TGA) 
Thermal stability of CMD scaffolds (n=3 for each type of scaffold) was assessed using a 
thermogravimetric analyser (TA Instruments, Q500) at a constant heating rate of 
10°C/min in over a temperature range of 25 to 825 °C in a controlled nitrogen gas 
atmosphere.  
3.2.2.5 Differential scanning calorimetry (DSC) 
Melting temperature and cross-linking of CMD scaffolds (n=3 for each type of 
scaffold)were analysed using a Mettler DSC820 system (Mettler Toledo, UK) at a 
constant heating rate of 10°C/min in over a temperature range of 25 to 100 °C in a 
controlled nitrogen gas atmosphere. 
3.2.2.6 Fourier transform infra-red (FTIR) spectroscopy 
A FTIR spectrometer (Thermo Scientific® Nicolet iS10) was used to analyse the 
secondary structure of proteins within the CMD scaffold (Kong & Yu, 2007; Ribeiro et 
al., 2012). Spectra were acquired from a 1.5 mm diameter sampling area (n=3 for each 
type of scaffold and n=3 measurements from 3 different spots per each sample) with a 
diamond crystal at a resolution of 4 cm
-1
 in the wave number region between 4000 and 
650 cm
-1
.  
3.2.2.7 Mechanical properties 
Compressive strength and modulus of the scaffolds (n≥7 for each group) with the 
dimensions of 6 mm in diameter and 2 mm height were measured in compression mode 
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at a crosshead speed of500µm/min using an Instron 5848 micro tester. The overall 
Young’s modulus was calculated obtained when materials were subjected from 0.7% 
strain to 95% strain. 
3.3 Results 
3.3.1 Bovine Articular Cartilage Water Content 
Weight measurements of wet and freeze-dried native bovine articular cartilage samples showed 
at average weight percentage of dry material in bovine articular cartilage to be 31 ± 3%, which 
is the maximum solid content of BAC samples (Figure 3-3).  
 
Figure ‎3-3: Weight measurements of wet and freeze-dried native bovine articular cartilage samples 
(n=33) showed the average weight percentage of dry material in bovine articular cartilage to be 31 
± 3%, which is the maximum solid content of BAC samples. 
3.3.2 Macro and Micro Morphologies of the CMD Scaffolds 
Figure 3-4shows the macroscopic morphologies and surface appearance of non-treated 
30% (Figure3-4: A), 15% (Figure 3-4: B), and 5% (Figure 3-4: C) CMD scaffolds. 
Samples show a highly porous spongy nature (Figure 3-4: D). While 15% and 30% 
CMD scaffolds retain their cylindrical shape, the 5% scaffolds look more deformed. 
Scaffolds showed substantial changes in the size after freeze-drying as compared to 
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their original mold size (shrinkage after lyophilization). Since there is a greater amount 
of water present in 5% CMD samples, the amount of total heat extracted from these 
samples during freeze-drying is much higher than those of 15% and 30% CMD 
scaffolds, leading to a higher level of shrinkage. However, differently treated samples 
displayed different rates of shrinkage suggesting that treatment plays a role in 
determining the shrinkage rate of the CMD scaffolds. 
 
Figure ‎3-4: Photograph of representative non-treated A) 30%, B) 15% and C) 5% CMD scaffolds. 
The inset image D) depicts the spongy elastic nature of a 15% CMD scaffold. 
15% and 30% UV and 15% UVDHT scaffolds showed the lowest shrinkage (25.9 ± 
1.5%, 25.9 ± 2%, and 25.3 ± 2.7%, respectively) among all treated CMD scaffolds as 
seen in Figure 3-5. One way analysis of variances showed no significant difference in 
shrinkage between the three mentioned groups (p>0.05). 
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Figure ‎3-5: Percentage of shrinkage in CMD scaffolds (n≥7‎ for‎ each‎ group)‎ with different 
concentrations and treatment methods.*: P>0.05. 
FESEM images in Figure 3-6 demonstrate the uneven and irregular shaped highly 
interconnected pores among the 5%, 15%, and 30% CMD scaffolds as a result of the 
freeze-drying scaffold fabrication method. Pore size analysis using ImageJ® showed an 
average pore diameter of 140 ± 60 µm for non-treated 5% CMD scaffolds, and 184 ± 60 
µm and 194 ± 61 µm for non-treated 15% and 30% scaffolds respectively (Figure 3-6: 
A-C). The average pore size in non-treated 5% CMD scaffolds is significantly lower 
than that of non-treated 15% and 30 % CMD scaffolds (Figure 3-7). As it can be seen in 
the FESEM images of UV treated CMD scaffolds (Figure 3-6: D-F), UV treatment did 
not affect the pore size of 5% scaffolds, but did demonstrate a moderate and mild 
increase in the pore sizes of 15% and 30% scaffolds respectively. The correlation 
between the shrinkage and pore sizes of the CMD scaffolds was small (R
2
=0.097). 
Shrinkage of the scaffolds during freeze-drying is not necessarily associated with a 
change in pore size since this is determined by the rate of cooling and annealing during 
the lyophilization process (Haugh, Murphy, & O'Brien, 2009). However, an increase in 
the pore size of 15% and 30% scaffolds was coincident with an increase in shrinkage, 
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suggesting that the degrading effect of UV on loose bands results in smaller scaffolds 
with bigger pore sizes. 
Image analysis of DHT treated scaffolds (Figure 3-6: G-I) shows a significant drop in 
pore sizes of 5% and 30% scaffolds as compared to a decrease in 15% scaffolds. 
As observed in Figure 3-9: J-L, UVDHT treated 15% and 30% scaffolds show the 
biggest pore sizes while the pore sizes of 5% UVDHT are smaller than the non-treated 
5% scaffolds. FESEM images of DHTUV samples (Figure 3-6: M-O) indicate big pore 
sizes for 15% samples, which are almost the size of those for the 15% UVDHT. 
However, a decrease in the pore sizes in 30% DHTUV scaffolds was observed. 
Interestingly, 5% DHTUV samples showed the biggest pore sizes. 
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Figure ‎3-6: FESEM images of CDM scaffolds with different concentration and treatments. The 
scale bars represent 1 mm. Inset images with the same scale bars are representative of colour 
thresholding through ImageJ® software used for pore size measurement. 
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Figure 3-7 shows the average pore sizes of CMD scaffolds with different concentrations 
and treatments (n≥50 for each group) derived from FESEM images using ImageJ® 
software. The 5% DHTUV, 15% UV, UVDHT and DHTUV, and 30% UV scaffolds 
showed the biggest mean pore diameters. However, one way analysis of variances 
between the five mentioned groups revealed no significant difference between them 
(P>0.05). 
 
Figure ‎3-7: Pore sizes of non-treated and treated CMD scaffolds with different concentrations and 
treatments (n≥50‎for‎each‎group), calculated form FESEM images using ImageJ® software. Asterix 
stands for P>0.05 (non-significant difference). 
 
3.3.3 Porosity of CMD scaffolds 
Porosity measurement using a modified microvolumetric Archimedes method showed 
an average porosity of 94% and above for all the different CMD scaffolds (Figure 3-8). 
Considering that the biggest difference between the porosities is still less than 4% 
among all the different groups, it is suggested that scaffolds may still be porous. In 
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addition, since these differences were significant, it may be that the resultant increase in 
surface area may provide better cell attachment and migration. 
 
Figure ‎3-8: Percentage of porosity of different scaffolds consisting of varying cartilage matrix 
concentrations and different treatments (n≥11‎for‎each‎group). Porosity measurements have been 
done through microvolumetric modification of liquid displacement method.*: P<0.05. 
Plotting the shrinkage against the porosity shows that by increasing the concentration of 
CMD from 5% to 15% the porosity of all treated and untreated scaffolds, the outcomes 
are not affected significantly (P>0.05).In contrast, a decreases in the shrinkage (P<0.05) 
except for DHT (P>0.05) can be observed. However, increasing the CMD concentration 
from 15% to 30% does not result in significant changes in the material shrinkage except 
for the DHT group, while the differences in porosity of different treatments remain 
significant (P<0.05). The results suggest that 15% CMD concentration is a critical value 
beyond which significant changes in porosity and shrinkage occurs (Figure 3-9).    
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Figure ‎3-9: Correlation between shrinkage and porosity among CMD scaffolds with different 
concentrations and treatments. Markers with small, middle, and big sizes indicate for 5%, 15%, 
and 30% cartilage matrix concentrations respectively. 
All 5% and 15% treated scaffolds showed a porosity of 98%, while the highest porosity 
among the 30% group was observed in UV treated scaffolds 96.7 ± 0.5%. This result 
indicates that when the scaffolds were shrinking, the shape and size changed 
significantly without much change in total number of pores, resulting in a homogeneous 
porosity of over 94% for all specimens. Furthermore, the higher porosity in few treated 
5% CMD scaffolds is indicative of breaking of the surface (as revealed in thresholding 
inset images in Figure 3-6 for 5% scaffolds) as a result of increased open porosity. Since 
30% CMD concentration is more than a critical value, which is in this pure water media 
15% CMD, the total number of pores also decreases with greater amount compared with 
5 or 15 % CMD scaffolds.     
Pluralization of shrinkage, pore size, and porosity data as major criteria in scaffold 
engineering suggests that although 5% and 15% DHTUV groups show big pore sizes, 
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but simultaneously show high percentages of shrinkage which fails them for selection as 
good scaffolds. 
On the other hand, the 15% and 30% UV and also 15% UVDHT groups show the 
lowest shrinkages, proportionally biggest pore sizes, and high porosities, and hence all 
three groups can be scaffolds of choice from the view of architecture.  
Considering all the above characteristics, including shrinkage, pore size and porosity of 
the entire CMD scaffolds and to confirm our selection, the other data of all 15% CMD 
scaffolds was assessed and characterized further. 
3.3.4 Compressive tests 
Figure 3-10 shows the results of mechanical testing in compression mode for all 
treatments of 15% along with 30% UV treated CDM scaffolds. UV and UVDHT treated 
scaffolds showed the highest compressive modulus (Ec) among other scaffolds, while 
one way analysis of variances showed that the Young’s modulus of DHT treated 15% 
scaffolds was not significantly different from that of UVDHT scaffolds (p=0.874). On 
the other hand, the 30% UV treated scaffolds exerted weak compressive strength and 
low Young’s modulus. Considering the maximum physiologic load applied on knee 
joint cartilage which is said to be 0.84-3.0 MPa for an average person, the Young’s 
moduli measured for 15% UVDHT and UV treated CMD scaffolds (0.274±0.05 MPa 
and 0.355±0.06 MPa respectively) falls between the range of 10-42% of compression 
moduli values of natural cartilage (Izadifar et al., 2012). The Young’s moduli for 15% 
UVDHT and UV treated CMD scaffold are significantly higher than untreated 15% 
CMD scaffolds and significantly higher than the compressive moduli reported for 
potential scaffold substitutes such as 1.5% and 2% agarose (9.0±0.3 KPa  and 76±5 KPa 
respectively) and mechanically enhanced agarose/PEG-dimethacrylate (51±3 kPa - 
93±4 kPa) hydrogels (G. Huang et al., 2012).   
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Figure ‎3-10: The compressive stress/strain representative curves of untreated and treated 15% and 
30% UV treated‎ CMD‎ scaffolds.‎ The‎ inset‎ graph‎ compares‎ the‎ Young’s‎ modulus‎ (n=7)‎ of‎
differently treated 15% CMD scaffolds. (*: P>0.05) 
3.3.5 Surface Morphology 
Figure 3-11 illustrates the surface topography changes in 15% CMD scaffolds after 
different cross-linking treatments, compared to the non-treated sample at higher 
magnification. The typical nano-structure of collagen fibrils, with their bands, is 
revealed in all samples by the very high magnification inset images in Figure 3-11. A 
ramous surface morphology can be seen in all treated samples while non-treated 
material shows no signs of dehiscence. It indicates that more cross-linking between the 
collagen polymer chains in the fibrils has occurred due to the different physical 
treatment. The DHT sample shows more surface cracks compared to other materials 
(Figure 3-11: C). On the other hand, UV and DHTUV treated materials (Figures 3-11: B 
& E) show the fewest cracks. In addition, the UV treated scaffolds show many network 
structures indicative of maximum cross-linking, and the UVDHT treated scaffolds are 
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moderately ramous. Considering these results, UV and UVDHT appear to have the 
more optimal surface morphologies, compared to the other treated or non-treated 
scaffolds.  
 
Figure ‎3-11: FESEM images of fibrous surface morphology of A) Non-treated, B) UV, C) DHT, D) 
UVDHT, and E) DHTUV 15% CMD scaffolds. The scale bars represent 10 µm (for insets 1µm). 
3.3.6 Thermogravimetric Analysis (TGA) 
All CMD materials show two main decomposition temperatures according to the two 
major weight losses (Figure 3-12). The first weight loss (10-16 wt %) appears at around 
265°C and is due to adsorbed moisture, adsorbed water and also collagen present in the 
material. The next decomposition (56-66 wt %) occurs at almost 720°C and represents 
the inorganic components in cartilage. 
Increases in thermal stability, which is measured in terms of the first decomposition 
temperature, is a result of and proportional to formation of cross-linked structures 
(Rodríguez-Baeza, Neira, & Aguilera, 2003). The 15% UV scaffold group showed the 
highest thermal stability of all treatments. The onset and offset temperatures of the first 
decomposition of 15% UV treated sample computed at 300.85 and 393.7 °C 
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respectively, which is higher than those of other treatments (see the inset in Figures 3-
12: A & B). The average weight residue after the first decomposition is 36 ± 4 % 
regardless of treatment for all 15% samples (see the inset in Figure 3-12: C). 
 
Figure ‎3-12: TGA of all the 15% CMDD scaffolds in nitrogen gas atmosphere at heating rate of 
10°C/min, A) onset and B) offset temperatures of 1st decomposition, and C) weight residue (%) 
after 1st decomposition of differently treated 15% CMD scaffolds in TGA. 
3.3.7 Differential Scanning Calorimetry (DSC) 
Figure 3-13 shows the DSC results and indicates melting points (Tm, in °C) of the 15% 
CMD scaffolds with different treatments. The 15% UV treated scaffold shows a 
significantly higher melting temperature compared to the other treated and non-treated 
scaffolds, indicating that it may have better mechanical properties which has already 
been shown in mechanical study. A higher melting point occurs due to the more cross-
linking present in the 15% UV treated scaffolds than in other non-treated or treated 
scaffolds. The cross-links may have been damaged due to thermal energy in other 
treated scaffolds or by other treatments.  
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Figure ‎3-13: DSC analysis of 15% CMD scaffolds with different treatments indicating the melting 
temperature of each treatment. 
3.3.8 FTIR 
The FTIR spectra of 15% CDM scaffolds with different treatments are shown in Figure 
3-14. Articular cartilage extracellular matrix (ECMD) derived scaffolds mainly consist 
of collagen II and proteoglycans. Amide I (C = O stretch), Amide II (N – H stretch, N – 
H bend combination), Amide III (C – N stretch, N – H bend, C – C stretch) and Amide 
A (N = H stretch) at wave numbers 1655, 1550, 1250 and 3330 cm
-1
, respectively are 
the representative bonds of collagen, while sulphate stretch (C – O – S stretch) occurred 
at 1125-920 and 850 cm
-1 
, Amide I (C = O stretch) at 1640 cm
-1 
and Amide II (N – H 
stretch, N – H bend combination) at 1545 cm-1 are characteristic of Proteoglycans 
(Camacho, West, Torzilli, & Mendelsohn, 2001; Petra, Anastassopoulou, Theologis, & 
Theophanides, 2005; Ribeiro et al., 2012; Saarakkala, Rieppo, Rieppo, & Jurvelin, 
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2010). All the characteristic FTIR peaks, including Amides I, II, III, and A as well as 
sulfate groups for collagen and proteoglycans are shown in Figure 3-14. 
 
Figure ‎3-14: Typical FTIR absorption spectra of 15% CDM material with different treatments. 
Wave numbers defined in blue and dark red are representative for collagen and proteoglycans 
respectively. The two sharp peaks at 2847 and 2915 on 15%UV are representative for alkane 
groups formed during UV treatment. 
The two sharp peaks at 2847 and 2915 wave numbers on 15%UV group spectrum are 
due to new alkane group formation from alkene groups during UV cross-linking 
treatment (Figure 3-14). The broken bonds from the alkenes in turn help the alkanes to 
make more crosslinks with the other chains of polymer collagens, as shown in Figure 3-
15. The more cross-links through UV in 15% CMD scaffolds would restrain the scaffold 
structure during cell culture study better than other treated scaffolds.  
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Figure ‎3-15: Alkene to alkane shifts will create new cross-linking bonds. 
Considering the sensitivity of the Amide III band at 1235 cm
-1 
to native collagen tertiary 
structure and C-H deformation related insensitivity of the absorbance at 1450 cm
-1
, the 
1235/1450 cm
-1
 ratio can help in quantification of degradation(Gilbert, 1988; Jus et al., 
2011). The ratio was 1.022 in untreated 15% CMD scaffolds and showed a decrease 
after treatment with UV (1.011) and UVDHT (1.008), indicating higher cross-linkage in 
initially UV treated samples, while increasing in DHT (1.030) and DHTUV (1.023) 
treated scaffolds resulting from a partial degradation in samples first treated with DHT. 
Our FTIR findings show that the effectiveness of physical treatment of CMD constructs 
is highly dependent on the concentration of CMD content in the construct. At low CMD 
concentrations (e.g., 5% CMD in our case) UV treatment causes more cross-linking, 
reconfirming the findings of Bellincampi and Dunn (Bellincampi & Dunn, 1997). When 
the CMD concentration is increased to 15% the DHT treatment forms a higher cross-
linking while UV treatment has more denaturation effects, which replicate the findings 
of a study on collagen fibers conducted by Weadock et al (K. S. Weadock, E. J. Miller, 
E. L. Keuffel, & M. G. Dunn, 1996). At the same time, alkene to alkane transitions 
provide supportive cross-linkings.   
3.4 Discussion 
ECM-based strategies are already established in tissue engineering (Benders et al., 
2013). Native cartilage ECM-derived scaffolds have been shown to support 
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chondrogenesis (Cheng, Estes, Young, & Guilak, 2011). Also, the effects of physical 
(UV and DHT) and chemical (carbodiimide) cross-linking treatments on chondrogenic 
differentiation and cell-mediated contraction of porous CMD scaffolds have already 
been studied (Rowland et al., 2013). However, the purpose of the current study was 
quantitative assessment of changes in the architectural and mechanical properties of 
physically cross-linked CMD scaffolds. 
Considering other studies done were only based on 3% (Q. Yang, Peng, Guo, Huang, 
Zhang, Yao, et al., 2008) and 10% (Cheng, Estes, Awad, & Guilak, 2008); CMD 
scaffolds and according to the proportional weight of dry material content in native 
fresh bovine articular cartilage, we produced bovine CMD scaffolds with three different 
concentrations of CMD material: 5%, 15% and 30% concentrations. 
The scaffolds underwent one of the five physical treatment conditions for cross-linking 
(Non-treated, UV, DHT, UVDHT, and DHTUV). Remarkable deformation and 
shrinkage after treatment, and small pore size were the major criteria to eliminate the 
5% scaffold group. UV and UVDHT treated15% scaffolds as well as UV treated 30% 
scaffolds showed the biggest pore sizes as compared to all other samples. Although UV 
treated30% scaffolds have the same concentration of dry material as the native cartilage, 
they showed a lower porosity, a relatively higher shrinkage, and a very low compressive 
strength compared to UV and UVDHT treated15% scaffolds. Structural stability, 
sufficient surface area for cell attachment, adequate space for diffusion of nutrients, cell 
migration and matrix deposition have been accounted as beneficial features of scaffolds 
with 95-97% porosity (Seal, Otero, & Panitch, 2001). UV and UVDHT treated15% 
CMD scaffolds showed high porosity rates (≈98%) and high Young’s moduli. The 
compressive moduli of these scaffolds appeared to be higher than pure and enhanced 
agarose and agarose/PEG (G. Huang et al., 2012), cell seeded porous scaffolds derived 
from native porcine articular cartilage (Cheng et al., 2011), and close to PEG 
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hydrogels(Bryant & Anseth, 2002) as potential alternative constructs for cartilage tissue 
engineering.  
While both UV and UVDHT treated 15% scaffolds showed high pore sizes, low 
shrinkages, and high porosities; UV treated 15% scaffolds showed a higher compressive 
strength, better thermal stability in TGA and DSC analyses as well as newly formed 
alkane peaks in FTIR which are obvious indicative of a higher degree of cross-linking. 
Crosslinking changes the mechanical strength of the scaffold due to breaking of 
unsaturated bonds and converting to primary bonds between the polymer chains as 
confirmed by FTIR study. The breaking of unsaturated bonds and consequent 
transformation into the primary bonds are mainly responsible to change the porosity in 
the CMD scaffolds as revealed in the SEM micrographs. The surface morphology of 
UV treated 15% scaffolds also showed an optimal intertwined collagenous surface that 
favours better cell attachment.  
DHT treatment has been reported to have beneficial effects in terms of providing bigger 
pore volume favouring cell attachment, proliferation, matrix production and cell-matrix 
interactions (Rowland et al., 2013). DHT treatment was also reported to increase the 
mechanical properties of collagen-glycosaminoglycan scaffolds (Haugh, Jaasma, et al., 
2009). Our findings indicate that although the compressive profile of DHT treated 15% 
CMD scaffolds as well as its porosity are as good as UVDHT treated CMD scaffolds, 
DHT treatment results in higher shrinkage and smaller pore sizes at 15% cartilage 
matrix concentration as compared to UV and UVDHT treatments. UV and UVDHT 
treatments on 15% CMD scaffolds can yield stiffer CMD scaffolds with low shrinkage 
rates that simultaneously possess optimal microstructure and biocompatibility. Our 
study employed 5%, 15% and 30% CMD scaffolds and, based upon data obtained 
suggests that 15% CMD concentration is a critical value beyond, which results in 
significant changes in porosity and shrinkage. 
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Therefore, fairly simple, feasible and cost effective UV and UVDHT treatments on 15% 
CMD scaffolds are promising candidates to provide the desired architecture while 
preserving bioactive factors, both of which are major concerns in the tissue engineering 
of scaffolds. 
Future studies are required to elucidate the particular chondroinductive capabilities of 
physically treated CMD scaffolds, and to further characterise the results of the present 
study. 
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CHAPTER 4: DEVELOPMENT OF MICROVOLUMETRIC 
MODIFICATION OF LIQUID DISPLACEMENT METHOD 
FOR POROSITY MEASUREMENT 
4.1 Introduction 
As discussed in Chapter 3, the measurement of porosity for light and highly porous 
materials has required the development of a novel technique. In this chapter we detail 
the wider background to such an undertaking, and the development of this technique. 
Porous materials find widespread applications almost in all the areas, covering 
engineering to medicine (Bertoldi, Farè, & Tanzi, 2011; H. Park & Miwa, 2003; Parrilli, 
2010; Pramanik et al., 2012). For these applications, the porosity and pore size have 
significant effect on different properties of porous materials. For instance, porosity is a 
highly determinant factor in fabrication of three-dimensional (3D) scaffolds in tissue 
engineering to mimic the extracellular matrix as templates onto which cells of various 
tissues attach, proliferate, move and function(Johnson, Bahrampourian, Patel, & 
Mequanint, 2010; Pramanik et al., 2012). Pore density is important in the fabrication of 
synthetic materials used in various applications such as filtration, bioreactors, analytical 
devices, prostheses etc. (Bradham, 1960; Fry, DeWeese, Kraft, & Ernst, 1964; 
Furneaux, Rigby, & Davidson, 1989). Therefore, it is essential that characterizations of 
the porosity of these materials be conducted accurately.  
Due to the importance, various methods have been developed to characterize the 
porosity, such as (BET) which uses the Archimedes’ principle based and computerized 
tomographic imaging techniques. Archimedes’ principle based liquid(Calvo, Bottino, 
Capannelli, & Hernández, 2008; Peinador et al., 2011) and gas(Szepes, Kovács, & 
Szabóné, 2005; Westermarck, 2000; Westermarck, Juppo, Kervinen, & Yliruusi, 1998) 
displacement as well as computerize tomographic imaging(Vergés, Ayala, Grau, & 
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Tost, 2008) methods of porosity measurement are routinely used for porous material 
characterization. Eligibility of application of each technique for different porous 
materials depends on their physiochemical properties. Although micro-CT is assumed 
as a gold standard technique for porosity measurement especially in biomedical field, it 
is not applicable to non-opaque materials. Cost and time-consuming process of data 
acquisition especially at high resolution rendering and the need for high performance 
imaging machinery and users are still important concerns and hence measuring the 
porosity through other methods is considered. Probable invalid equation due to absence 
of a truly linear region, shrinkage of some samples, need of degassing thermal 
preparations, limited nitrogen gas adsorption with highly porous solid samples(Kissa, 
1999) and restrictions with the minimum sample size(Sharif, DiMemmo, Davidovich, & 
Sarsfield) and cost are some limitations with BET surface area analysers. Cost-
effectiveness and feasibility have been the main reasons that Archimedes’ principle 
based liquid displacement methods are still favourable. However, determining the 
porosity of non-opaque small sized highly porous light materials through these methods 
has always been a big concern. However Archimedes’ principle based and micro-
computerized tomography (micro-CT) techniques are comparatively better. In micro-
CT, pore distributions from several tomographical images, generally developed by X-
ray, are combined together to get total porosity of small 3-D scaffolds. Variations of 
Archimedes’ principle based liquid displacement method are still favourable due to their 
simplicity, inexpensiveness and ease of use for determination of porosity of solid 
materials with irregular shapes. Suspension (Figure 4-1: A), level (Figure 4-1: B), and 
overflow (Figure 4-1: C) methods are three different modifications of liquid 
displacement using the same Archimedes’ principle. It has been shown that suspension 
technique is the most preferred method in terms of accuracy and precision(Hughes, 
2005).  
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Figure ‎4-1: Schematic diagram of the A) suspension, B) level and C) overflow methods of 
measuring volume. 
However, there are several limitations associated with these methods. For instance, the 
accuracy of each method depends on how delicate the weight or volume changes are 
read. On the other hand, precision and accuracy of the method depend on the readability 
of the weighing scale or volumetric readings. Moreover, the sample is to be suspended 
stationary in the liquid by means of a string line, which can affect the readings by 
exerting a tension effect. Considering the weight and geometry of the sample, the string 
weight and volume may also not be negligible. Thus, suspension method cannot be used 
for small and very lighter objects. Overflow method on the other hand may not be 
applicable to very light and highly porous materials due to their geometry and the 
limitations caused by surface tension.  
Therefore, there is still an unmet need for a much precise method for porosity 
measurement of ultra-light highly porous materials. In this study, we aim to develop a 
very precise and accurate modification of the “Level” method, which is consistently 
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applicable for very small and light objects up to the volume of only few microliters such 
as those used within this thesis. 
4.2 Materials and Methods 
4.2.1 Experimental Set up 
A 10 ml glass pipette with an internal diameter of 7.2 mm was used for the experiment. 
The narrow tip of the glass pipette was cut and the other side was sealed with a rubber 
cap. A small magnetic bar (29x6 mm, 3 g) along with a modified insulin syringe 
plunger was inserted in the pipette to assist in taking out the soaked sample from the 
glass pipette. (Figure 4-2) 
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Figure ‎4-2: components of Microvolumetric liquid level displacement method for porosity 
measurement: A) magnetic bar, plunger from insulin syringe, and 10 ml glass pipette end sealed 
with rubber cap 2) Set up and vertical alignment of the measuring pipette and its internal 
components. 
An OCA 15EC optical contact angle measuring instrument, dataphysics®, Germany 
was used to capture the images more perfectly during test. The sample table for contact 
angle measurement was replaced with the glass pipette, which was totally aligned and 
fixed vertically in between light source and the camera. (Figures 4-2: B and 4-3) 
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Figure ‎4-3: Laboratory set up for modified microvolumetric level displacement method for porosity 
measurement. The measuring glass pipette with its components aligned vertically in between the 
light source and the digital camera. The monitor shows the liquid level. 
The glass pipette was filled up to the lens vision level with liquid hexane (Fisher 
Scientific # H/0421/PB17), which can be clearly observed on the computer monitor. 
Hexane is as an inert, cheap, relatively safe and colourless liquid. The digital level 
marker was adjusted at the liquid level after proper focusing and the image was captured 
on the computer screen (Figure 4-4: A). Using a micropipette, 100 µl of hexane was 
added to the previous level (Figure 4-4: A) and the second image was captured with a 
new liquid level marker. The distance between the two markers was later used for scale 
calibration with the image processing software (Figure 4-4: B). This calibration step is 
most important to validate our technique as precise and accurate. The new level was 
assigned as the new reference baseline. 
4.2.1.1 Microvolumetric Measurements 
Using a fine tip tweezer and side pinching with agility, the sample was moved into the 
standing pipette and let to sink. Once the sample was sat on the plunger surface, the 
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elevation of the liquid level inside the pipette from the baseline was marked with a level 
cursor on the computer and the image was captured (Figure 4-4: C). An external U-
shaped permanent magnet was used to pull up the suspended sample, which was sitting 
on top of the plunger, with help of inside magnetic bar in the glass pipette, and then it 
was removed with the tweezer from the glass pipette. The plunger was left to settle back 
down the pipette. The liquid level marker was established and the last image was 
captured (Figure 4-4: D). 
 
Figure ‎4-4: Microvolumetric level method for porosity measurement: A) Baseline establishment, B) 
Level calibration with 100 µl volume and second level establishment, C) V1: level elevation after 
immersing the sample, and D) V2: Volume depletion after removing the sample. 
Changes in the hexane level in the pipette from the baseline after calibration were 
recorded. When the sample was immersed in the pipette, it sank into the hexane and sat 
on top of the plunger surface and the hexane level elevated to a higher level compared 
to the baseline. This volume change was recorded by the digital camera and called (V1), 
representing the absolute volume of the sample. After removing the sample the hexane 
level dropped to a lower level compared to the baseline. The image of this volume 
depression which was called (V2) and represented the pore volume in the sample was 
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captured by the camera using a SCA20 software version 4. 2. 4. (dataphysics® 
Instruments). Changes in the hexane level were precisely measured through length 
measurement using ImageJ® 1.47v software. The volume calibration image was used to 
convert length to volume through imageJ® software. 
Percentage of total pore volume was calculated as:  
Total pore volume =
V2
V1+V2
 100 % 
Where, V1 is volume change after immersing the sample (absolute volume = volume of 
solid matter without pores) and V2 is volume change after removing the sample (pore 
volume). 
4.2.2 Validation of Microvolumetric method 
To assess the accuracy and precision of the microvolumetric method of porosimetry 
three standard porous samples were prepared. Two groups of porous alumina made of 
alumina/poly-(ethylene oxide) composites with different ratios were fabricated by 
means of sintering. Briefly, 5.45 g and 5.62 g of poly(ethylene oxide) (density: 1.21 
g/cc) were mixed homogeneously with 0.86 g and 0.81 g of Al2O3 (density: 3.95 g/cc), 
respectively and then the mixture powder was pelletized in a stainless steel mould at 
room temperature at 100 MPa uniaxial pressure using a hydraulic press. The pellets 
(10 mm  5mm) were then sintered at 1000°C temperature for 3 hours in nitrogen 
atmosphere to get 65% and 70% porous alumina structures, called alumina1 and 
alumina2, respectively. Sintered porous glass bars (R & H Filter Co. Inc, Georgetown, 
USA) with dimensions of 4 mm x 5 mm x 50 mm and porosity of 61.5%, as supplied by 
manufacturer, also were selected as the third standard porous material (Figure 4-5: A). 
Porosity measurement of standard porous samples was carried on through both 
microvolumetric method and micro-CT imaging. 
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4.2.2.1 Field Emission Scanning Electron Microscopy (FESEM) 
FESEM was performed using a Quanta
TM
 250 FEG – FEI microscope to confirm the 
outer surface porosity of the fabricated porous samples. 
4.2.2.2 Micro-CT 
Micro-CT has been widely used as one of the best techniques to show the total pore 
volume and porosity present in a material with complex geometry (Bertoldi et al., 2011; 
H. Park & Miwa, 2003; Parrilli, 2010; Zhang Yang & Xiaofeng, 2007). Therefore, three 
replicates of each standard porous group were subjected to micro-CT imaging for 
porosity analysis using a SkyScan-Bruker 1076 in vivo micro-CT (parameters: voltage: 
59 kV, current: 100 uA, filter: Al 0.5 mm, resolution: 18 µm, rotation angle: 180°, 
rotation step: 0.7°, and number of scan slice: 100). Samples were mounted on 
polystyrene foam prior to CT scanning. 
4.2.3 Statistical Analysis 
A Bland-Altman analysis(Altman & Bland, 1983; Bland & Altman, 1986) was used to 
assess agreement between two methods of porosity measurement with the actual values. 
XLSTAT® version 2014.1.05 package for Excel® (2007) was used for data analysis. A 
range of agreement was defined as mean bias ±2 standard deviation (SD). 
4.3 Results 
Actual size of the sintered porous pellets from three different porous materials is shown 
in Figure 4-5(A). Micro-CT and FESEM images shown in Figures 4-5(B) and 4-5(C-E) 
clearly show the porous structure of representative porous alumina1 and alumina12, and 
glass samples.   
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Figure ‎4-5: Digital photographs (A), Micro-CT 3D rendering images (B), and FESEM micrographs 
(C-E) of representative porous alumina1, glass, and alumina2 samples respectively. 
The original results of porosity measurement by micro-volumetric and micro-CT 
methods along with the actual porosities for two types of porous different sintered 
alumina scaffolds and glass scaffolds are illustrated in Table 4-1. As it can be seen, total 
mass volume of the samples are to the scale of only few hundred microliters and volume 
measurements have been done to the resolution of less than one microliter. 
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Table ‎4-1: Micro-volumetric and micro-CT porosities compared with the actual porosity, mean and difference between each method and the actual value. 
 
Samples V1 
(µl) 
V2 
(µl) 
Actual Porosity 
(%) 
Porosity from 
micro-volumetric 
(%) 
Mean:  
Actual and Micro-
volumetric 
Difference: Actual 
and Micro-
volumetric 
Porosity from 
micro-CT 
(%) 
Mean:  
Actual and Micro-
CT 
Difference: 
Actual and Micro-
CT 
Alumina 1-1 59.2 112.5 65 65.5 65.3 -0.5 40.6 52.8 24.4 
Alumina 1-2 55.6 107.5 65 65.9 65.5 -0.9 74.1 69.6 -9.1 
Alumina 1-3 56.6 109.5 65 65.9 65.5 -0.9 79.1 72.0 -14.1 
Alumina 2-1 66.7 142.2 70 68.1 69.0 1.9 73.3 71.6 -3.3 
Alumina 2-2 61.9 131.9 70 68.0 69.0 2.0 83.4 76.7 -13.4 
Alumina 2-3 55.6 119.4 70 68.3 69.1 1.7 84.3 77.1 -14.3 
Glass 1 172.8 274.5 61.5 61.4 61.4 0.1 55.9 58.7 5.6 
Glass 2 241.4 389.9 61.5 61.8 61.6 -0.3 70.9 66.2 -9.4 
Glass 3 107.5 170.8 61.5 61.4 61.4 0.1 79.6 70.5 -18.1 
86 
Figure 4-6compares the measured porosity through micro-volumetric and micro-CT 
methods with the actual porosity of porous glass, alumina1, and alumina2 materials. 
While the values obtained from micro-volumetric method are almost equal to the actual 
porosities, with small standard deviations, the values gathered from micro-CT are 
different from actual porosity and have very big standard deviations. 
 
Figure ‎4-6: Comparison between the measured porosity through micro-volumetric and micro-CT 
methods with the actual porosities of porous glass, alumina1, and alumina2. 
Figure 4-7(A) shows the scatter plot of measured porosity through micro-volumetric 
and micro-CT methods versus actual porosity values. There is a strong correlation 
coefficient of R
2
=0.92 for micro-volumetric and actual porosities while that of micro-
CT method and the actual porosities is only 0.14, indicating a weak correlation between 
the micro-CT and actual porosities. Figure 4-7(B) represents the Bland-Altman plot of 
the difference versus mean porosities of each pairs of data, indicating an almost 
consistent difference at various average porosities between the micro-volumetric and 
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actual porosity compared to the changing difference for different values of mean 
porosity between micro-CT and the actual.   
Figure 4-7(C) also shows the Bland-Altman plots of the data with the bias and precision 
lines for both micro-volumetric and micro-CT methods. The accuracy (bias= -0.023) 
and precision (confidence interval: -0.459, 0.413) for micro-volumetric method is much 
higher than that of micro-CT method (Bias = 6.1, CI: -21, 33.1).  
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Figure ‎4-7: A) Scatter plot of measured versus actual porosity and the corresponding regression 
coefficients for Micro-volumetric and Micro-CT methods, and B) scatter plot of difference versus 
mean porosity of Micro-volumetric and Micro-CT with actual porosity, and C) Bland-Altman plots 
of the data showing the level of agreement between measured and actual porosities. The solid lines 
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indicate the accuracy and the square dotted lines represent the precision of the two techniques. 
95% of the data are expected to fall within‎±1.96Ơ. 
4.4 Conclusion 
In this chapter, a revised modification of Archimedes’ principle based liquid level 
displacement method to increase the accuracy and precision of porosity measurements 
of small light highly porous materials for many advanced applications is hereby 
presented. Our method consists of using a pipette as a more delicate measuring cylinder 
along with the improved sample loading and removal system, and taking advantage of 
digital imaging and computer assisted image processing to increase the performance of 
liquid level change readings.  
Our findings show that the precision and accuracy of our modification of Archimedes’ 
method of porosity measurement is much higher than that of Micro-CT. Although each 
group of our standard samples were fabricated with constant conditions, micro-
volumetric method shows similar results with a small standard deviation for each type 
of construct, while micro-CT method fails to do so. We achieved an excellent precision 
and accuracy in porosity measurements. The readability of microvolumetric method is 
down to 1 µl volumes. 
This method is applicable to any porous material regardless of opacity, lightness, shape 
and degree of porosity. Taking advantage of the magnetic bead/plunger escalator 
technique instead of a variable size string to suspend the sample, high performance lens 
with integrated continuous fine focusing ability, and adjustable observation and camera 
tilt angle, minimize the measurement errors and brings in a high precision and accuracy 
to the measurements. 
Microvolumetric level method is one of the most accurate and precise methods of 
porosity measurement for ultra-light highly porous materials. Simple design, feasibility, 
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open source ImageJ® software and straight forwarded results all are the benefits of this 
modification. 
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CHAPTER 5: ISOLATION, CULTURE AND CHARACTERIZATION OF 
HUMAN DERMAL FIBROBLASTS 
5.1 Introduction 
There are two main strategies for isolation of human dermal fibroblast cells: enzymatic 
digestion of skin samples and the outgrowth (explant) method. Whilst enzymatic 
digestion can shorten the HDF production time, it often yields a non-homogeneous 
population of fibroblasts, therefore, the explant method is preferred when one seeks to 
isolate a pure population of HDF cells within 3 to 4 weeks (Froget et al., 2003). Further, 
the explant method can yield high motility cells, which are more suitable for tissue 
engineering applications in terms of their better penetration into the scaffolds (Rittié & 
Fisher, 2005). 
In this chapter we explain the explant method for HDF cell isolation with minor 
modifications. Subculture and preservation of HDF cells as well as characterization are 
also described. 
5.2 Materials and Methods 
5.2.1 Cell Isolation 
Ethical approval for this study was obtained from the University of Malaya Medical 
Centre (UMMC) ethics committee (PPUM/MDU/300/04/03, 22 April 2011). Redundant 
human skin from cosmoplastic surgery was procured from the UMMC operating 
theatre. Preferably, skin from non-sun-exposed areas of the body of female subjects was 
used for cell cultivation. The average age of the subjects was 27.5 ± 15 years. The 
minimum and maximum ages were 8 and 42 years respectively. Preoperative 
antimicrobial preparation (prep and drape) was done as the routine technique prior to 
incision. After excising the extra full-thickness skin, in some occasions along with the 
underlying fat tissue, the tissue was dipped in Povidone Iodine and then 70% ethanol, 
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each for 5-10 seconds. The skin sample was then washed with sterile saline and 
immediately transferred to a cell culture clean room in a sterile container with saline and 
3-5X Antibacterial-Antifungal solution (Penicillin 100 IU/mL, Streptomycin 100 
μg/mL, and Amphotericine B 0.25 μg/mL). The rest of the work was carried out inside a 
laminar flow biological safety cabinet. The skin samples were transferred to another 
sterile container with wash medium containing DMEM-HG (4.5g/l glucose) with L-
glutamine and Sodium Pyruvate [cellgro® #10-013-CM] and 3X Penicillin-
Streptomycin-Neomycin Solution [GIBCO # 15640]. Any remaining Infradermal fat 
was removed (Figure 5-1, A-C). The skin was first cut into strips of 0.5-1 cm
2
. The 
epidermis was dissected from dermis using scalpel and surgical blades (Figure 5-1, D). 
The dermis then was minced to 0.5-1 mm
2
 pieces (Figure 5-1, E&F). Nunc 
EasYFlask™ Nunclon™ T25 tissue culture flasks were pre-wetted with working 
medium (DMEM with 4.5g/l glucose, L-glutamine and Sodium Pyruvate [cellgro® #10-
013-CM] supplemented with 20% FBS [SIGMA # F1051] and PSN [GIBCO # 15640]) 
and left to dry out inside the laminar flow biological safety cabinet. 5-10 minced dermal 
pieces were transferred to each flask and incubated (Figure 5-1, G-I). 30-45 minutes 
later 1-2 drops of working medium per each skin piece was gently added to the flasks on 
top of each sample. The flasks were incubated in 5% CO2 at 37°C. The flasks were 
checked for possible drying of medium and 1-2 drops of working medium was added on 
top of each skin sample when necessary. After 3 days, and thereafter every 2-3 days, the 
medium was changed, until the cells started to grow, then the concentration FBS in 
working medium was decreased to 10%.  
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Figure ‎5-1: Outgrowth method for HDF isolation. A) Full-thickness skin washed in DMEM + 3-10X 
Antibiotic solution, B & C) Dissecting infradermal fat layer, D & E) Dissecting Epiderm from 
Derm, F) Mincing the Derm, G, H & I) Putting small minced derm samples in pre-wetted T25 flask. 
 
5.2.2 Cell Harvesting 
After the cells started to grow, the skin pieces were removed and cultured in new flasks 
with the same described method, and the same process was followed again. Cell 
isolation from the same skin pieces was repeated up to six times. After the flasks 
reached confluence of up to 70-100% passaging was done using TryPLE Select
®
 
[GIBCO# 12563011]. Briefly, the medium was removed and discarded and cells were 
gently washed with pre-warmed (37°C) PBS. After discarding the PBS, 2ml of TryPLE 
Select® was added to each T25 flask and incubated at 37°c for 3-15 minutes with 
intermittent monitoring under an inverted phase microscope (Nikon ECLIPSE TS100) 
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for cell detachment. Cell detachment was enhanced by tapping the flask. 5 ml working 
medium was added to each T25 flask to inactivate the TryPLE Select®. The cell 
suspension was transferred to 15 ml centrifuge tubes and spun at 220 RCF for 5 
minutes. The supernatant was gently removed and the cell pellet was resuspended in 
1ml fresh medium.  
5.2.3 Cell Count and Viability (Dye Exclusion Method) 
Preparation of Trypan Blue Solution 
0.2 gm Trypan Blue (Sigma Catalog # F-7378) was dissolved in 99.8 ml Ultra-pure 
water and filtered through a 0.45µm hydrophobic membrane syringe filter (Thermo 
SCIENTIFIC Catalog # 9057). 0.2% Sodium Azide (Sigma Catalog # S2002) was 
added to make a stock solution. 2 ml stock solution was added to 0.43 gm Sodium 
Chloride (NaCl) in 9.58 ml Ultra-pure water to make the Trypan Blue working solution.  
Cell Count and Viability 
20 µl of the cell suspension was transferred to a 1.5 ml micro-centrifuge tube and 
topped up with the same amount of Trypan Blue working solution. After placement of a 
cover slip (Hausser Scientific, Horsham, PA) on a Bright-line Haemocytometer, 20 µl 
of Trypan Blue/cell suspension mixture was transferred to each of the two chambers of 
the haemocytometer. 
The unstained (viable) and stained (nonviable) cells were counted separately in the 
haemocytometer. The total number of viable cells was multiplied by 2 (the dilution 
factor for trypan blue) to obtain the total number of viable cells per ml, and the total 
number of viable and nonviable cells were added up to obtain the total number of cells 
per ml. 
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5.2.3.1 Subculture of HDFs 
According to the cell count results 5x10
3
 cells per square cm were transferred to new 
T75 flasks. 12-15 ml fresh working medium was added to each flask and incubated at 
37° in a 5% CO2 humidified incubator. Sub-culturing the HDF cells was continued up to 
Passage 4 and then cryopreservation was done. 
5.2.3.2 Cryopreservation 
At passage 3, when the cells reached confluence, the medium was discarded and the 
cells in the T75 cell culture flask were washed twice with 10-15ml pre-warmed 
Phosphate Buffered Saline (PBS). PBS was discarded and cell harvesting was carried 
out using TryPLE Express
®
 through the previously described method. After spinning 
the cell suspension at 220 RCF for 5 minutes and discarding the supernatant, the cell 
pellet was resuspended in 1 ml of working medium. Cell counting was performed. The 
cell suspension, with a density of 10
6
-10
7
cells/ml, was transferred to a 2 ml cryovial and 
7% Dimethyl sulfoxide (DMSO) [SIGMA#2650] was added to each vial. The cryovial 
was labelled, kept at room temperature for 30 minutes for equilibration, placed in a Mr 
Frosty™ freezing container (Thermo Scientific), and moved to a -80ºC freezer and left 
overnight. The next day, the cryovial was shifted to a liquid nitrogen tank for long-term 
conservation. 
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5.2.4 Resazurin Standard Curve for HDFs 
Determining cell number and viability without the need to harvest or digest cells 
provides certain advantages. It allows the researcher to track the changes in cell number 
precisely, without the need of inference, and also to the see the changes to cells as the 
result of external factors in real time. Resazurin (7-Hydroxy-3H-phenoxazin-3-one 10-
oxide) has been used as a non-toxic cell number/viability quantifying assay with a 
variety of cell types (Dienstknecht et al., 2010; Gago et al., 2009; Jeney, Bazsó-Dombi, 
Oravecz, Szabó, & Zs-Nagy, 2000), bacteria (Lorenz et al., 2008; Riekstina, Muceniece, 
Cakstina, Muiznieks, & Ancans, 2008; Rutherford et al., 2002) and fungi (Xu, Rao, 
Zhu, & Chai, 1993) since the reagent was first introduced in 1929 (Pesch & Simmert, 
1929). The indigo blue and non-fluorescent Resazurin can easily diffuse through cell 
membranes without harming the cells. A significant overtime reduction of 
AlamarBlue® dye co-incubated with post-mitochondrial fractions of murine hepatic 
cells has shown the role of microsomal, mitochondrial and cytosolic enzymes in 
intracellular metabolism of Resazurin (R.J. Gonzalez, 2001). Resazurin is oxidized 
inside the cells and turns into pink fluorescent Resurfin (Figure 5-2).  
 
Figure ‎5-2: The bluish Resazurin passively diffuses into the cells and gets oxidized into pinkish 
Resurfin which diffuses back into the intercellular space. 
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Both Resazurin reduction and Resurfin production can be measured through 
colorimetric and fluorometric readings respectively. This helps to visually identify the 
metabolic activity of the cells which suggests that cells are indeed viable. Cost-
effectiveness, safety, ease and feasibility of long term use and good correlation to other 
reference cell viability assays as well as feasibility of the application of other 
chemiluminescent assays are the reasons of the superiority of Resazurin among other 
assays (Chen et al., 2007; Dienstknecht et al., 2010; Rampersad, 2012).  
Although Resazurin has been used to assess viability in a wide range and number of 
animal and human cells including Swiss 3T3 mouse fibroblasts (Voytik-Harbin, 
Brightman, Waisner, Lamar, & Badylak, 1998), rat hepatocytes (O'Brien, Wilson, 
Orton, & Pognan, 2003), Retinal Pigment Epithelial Cells (RPEs) (Yu, Chung, Yu, Seo, 
& Heo, 2003),  and Mesenchymal Stem Cells (MSCs) (Dienstknecht et al., 2010), its 
suitability for use with primary HDFs has not yet been shown.  
In this study, varying densities of primary HDF cells in monolayer culture on TCP were 
subjected to four different formulations from two commercial brands of Resazurin dye 
at varying incubation times. We show HDF attachment rate on TCP 4 hour after cell 
seeding. We report a detailed method to determine the most reliable formulation for dye 
preparation, Resazurin standard curve for primary HDFs, and also suggest a “Resazurin 
Reduction Nomogram” as a graphic tool for quantification of monolayer cultured 
primary HDFs based on Resazurin absorbance.  
5.2.4.1 Cell Seeding 
HDF cells at passage 5 were seeded at different densities (2, 6, 20, 50, and 100 x10
3
 
cells/well) in quadruplicates in six separate Nunc® 24-well plates pre-wetted with 
working medium. The last well in each row was left unseeded as blank. Wells including 
the blank were topped up to a final volume of 500 µl with working medium and 
incubated in 5% CO2at 37°C for 4 hours.  
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5.2.4.2 Cell Attachment 
Four hours after cell seeding two of the 24-well plates with different cell densities were 
removed from the incubator and subjected to trypsinization and cell harvesting. The 
cells from each well were collected in separate 1.5 ml microcentrifuge tubes and span 
for 5 min at 220 RCF. After removing the supernatant, the cell pellets were resuspended 
in 200 µl of fresh medium and cell count using the Trypan-blue and haemocytometer 
method was performed. The average ± SD cell number attached on TCP surface, 4 
hours after seeding varying cell densities was calculated. 
5.2.4.3 Dye Preparation 
To prepare the stock solutions, the Resazurin sodium salt powder (Sigma-Aldrich # 
R7017) was dissolved in Phosphate Buffered Saline (Sigma-Aldrich # P4417) solution 
and Phenol red-free Dulbecco’s Modified Eagle’s Medium (DMEM) (Sigma-Aldrich, 
Cat No.: D5921) separately at a concentration of 140mg/liter according to the 
instructions from Sigma technical support team. AlamarBlue
®
 (Life Technologies # 
DAL1100) readymade stock solution was also purchased from a local company. The 
stock solutions where then re-diluted with either PBS or Phenol red-free DMEM to 
make 10% working solutions. 
5.2.4.4 Resazurin Assay 
4 hours after cell seeding and incubation the 24-well plates were also checked under an 
inverted microscope for cell attachment. The working medium was removed gently and 
discarded. 3ml of either pre-warmed 10% AlamarBlue® in PBS or AlamarBlue® in 
DMEM or Resazurin in PBS or Resazurin in DMEM was added to each well and the 
well-plates were re-incubated. After 50 minutes all four well-plates were wrapped in 
aluminum foil and shaken at 60 rpm for 10 minutes on an orbital shaker. Duplicates of 
100 µl of the dye from each well were transferred to a TPP 96-well-plate and the 
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absorbance was measured in the plate reader (FLUOstar OPTIMA (BMG LABTECH) 
at 570nm and 595 nm. Measurements were repeated every 1-2 hour up to 22 hours. The 
following manufacturer’s formula (Gang et al., 2004) was used to calculate the 
percentage of AlamarBlue®/Resazurin dye reduction:  
(εOX)λ2 Aλ1 −  (εOX)λ1 Aλ2 of test agent dilution
(εOX)λ2 A°λ1 −  (εOX)λ1 A°λ2 of untreated positive growth control
 x 100 
Where:  
εOX = molar extinction coefficient of AlamarBlue oxidized form (BLUE) 
εRED = molar extinction coefficient of AlamarBlue reduced form (RED) 
A = absorbance of test wells 
A° = absorbance of positive growth control well 
λ1 = 570nm  
λ2 = 600nm 
% reduction in Resazurin at different cell densities was plotted against time to get the 
Resazurin Standard Curve for Human Dermal Fibroblasts.  
5.2.5 HDF cell doubling time 
Cells in culture proliferate on a binary fission basis; on the other hand each cell cleaves 
into two equal cells at an invariant rate. When the duration of time per cell repartition is 
known, population sizes can easily be predicted. The mean generational time (the time 
the cells need to double) can be calculated from population sizes at given times.  
Generation of a growth curve is useful in evaluating the growth characteristics of the 
cells particularly when growth kinetics of cells on a special material is considered. From 
a growth curve, the lag time, logarithmic population doubling time and the stationary 
phase (saturation) density can be determined. The results are plotted on a log-linear 
scale, then the population-doubling time can be determined by identifying the cell 
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number along the exponential phase of the curve, tracing the curve until that number has 
doubled, and calculating the time between the two. 
Methods 
HDF cells were seeded at a density of 25x10
3
 cells/well in pentaplicates in 6-well plates 
(TPP, Switzerland) pre-wetted with 500 μl of working medium. The last well in each 
plate was left unseeded as the blank. After 4 hours of incubation in 5% CO2 and 37°C 
all wells including the blank were topped up to a final volume of 3ml with working 
medium and re-incubated.  
Five aliquots of cell suspension with the same density (2.5 X 10
4
) were also prepared 
for total DNA quantification through Hoechst 33258 method. 
Resazurin reduction test, cell count, and DNA quantification were performed at 24 h 
intervals every day.  
DNA Quantification 
Preparation of EDTA/PBE solution 
10 mM (0.02922g) Ethylenediaminetetraacetic acid (EDTA) white powder (SIGMA 
#E6758) was dissolved in 100ml PBE (pH=7.8) and labelled properly, then autoclaved 
and left to cool down. (The EDTA will not dissolve in PBE unless its pH is adjusted to 
7.8) 
Preparation of DNA Standard 
5 mg Deoxyribonucleic acid sodium salt from calf thymus Type 1 fibres (SIGMA 
#D1501) was weighed using a SHIMADZU AY220 Analytical Balance in sterile 
condition and dissolved in 5.00 ml of EDTA/PBE solution in a small sterile glass 
container inside the laminar flow hood. The container was left in a 0-4°C fridge 
overnight (≥16 hours). Once in a while the container was shaken gently. After around 
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12 hours the DNA started to make a gel. To shear the DNA, it was pipetted up and 
down several times using a sterile glass pipette. The DNA was filtered through a 0.45 
µm syringe filter (minisart SRP15, Sartorius, Germany) after it was fully dissolved. The 
precise DNA concentration was checked with a Nanodrop ND2000 (Thermo Scientific). 
As DNA tends to be absorbed onto the plastic surfaces, it was aliquoted in 1-2ml bijou 
tubes and frozen at -20ºc. (This way the DNA standard solution can be stored for 
several months without significant degradation)  
Hoechst Stock Solution 
50mg of Hoechst 33258 (SIGMA #861405) was dissolved in 25.00 ml of ultra-pure 
water in a light-tight bottle to make 2mg/ml Hoechst stock solution. 
Preparation of TEN Buffer 
A mixture of 10 mM Tris, 0.2 M NaCl, and 1 mM EDTA in PBS was prepared, 
autoclaved, and the pH was adjusted to 7.4. The TEN buffer was used for diluting the 
Hoechst stock solution to a working solution of 0.2 µg/ml. 
Papain Digestion 
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1.5625µg/
ml 
3.125µg/
ml 
6.25µg/ml 12.5µg/ml 25µg/ml 50µg/ml 
At each daily time point, pentaplicates of cells in the 6-well plate were trypsinized and 
harvested and subjected to Papain digestion after performing a Resazurin test and cell 
count.  
1 ml of digest buffer with the following formula was added to each cell pellet. 
Digest buffer ingredients: 
 L-Cystein HCl (Sigma # C1276) 0.1576 g 
 EDTA (Sigma # E6758)  0.0806 g 
 PBS     100.00 ml 
3 µl (~5 KU) of Papain (Sigma # P5306) was added to each tube and incubated in a 65ºc 
oven for 1 hour with intermittent vortex-mixings. The digests were centrifuged at 
10,000 RPM for 10 min to sediment the residual debris. The supernatants were then 
ready for DNA quantification. 
 
Standard DNA Curve 
Serial dilutions of standard DNA were made at 50, 25, 12.5, 6.25, 3.125, 1.5625, and 
0.78125 µg/ml with PBE (Figure 5-3). Triplicates of 40µl of each dilution along with 
triplicates of each cell digest sample were transferred to a black, flat dense bottom 96-
well-plate (Falcon, Corning # 3916). 200 µl of the working Hoechst solution (0.2 
µg/ml) was added to each well in a dark room. Wrapped in Aluminium foil the 96-well-
plate was transferred to the microplate reader (FLUOstar OPTIMA BMG LABTECH) 
and absorbance was read at excitation: 570 nm and 595 nm. An R
2
-value of ≥ 0.95 for 
the standard DNA dilution concentration against optical density was accepted.   
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Figure ‎5-3: Preparation of serial dilutions of standard DNA. 
5.2.6 Characterization of HDFs 
5.2.6.1 Morphology: 
The morphology of HDFs on tissue culture polystyrene was studied using an inverted 
phase microscope. Also Confocal and FESEM micrographs of HDFs seeded on collagen 
scaffolds (precisely described in Chapter 5) were used for HDF cell morphology.  
5.2.6.2 Tri-lineage Differentiation 
Tri-lineage differentiation was performed to rule out the possibility of presence of stem 
cells in HDF population. HDF cells at passage 4 were used for Tri-lineage 
differentiation. Human Bone Marrow Stem Cells (HBMSC) was also used as the 
positive control group. Immediately after thawing the cells they were washed with fresh 
medium and centrifuged at 220 RCF for 5 minutes. The supernatant was discarded and 
the cell pellet was resuspended in 1 ml of fresh medium. Cell count and viability test 
was done using Trypan Blue solution and Neobar Hemocytometer.  
Adipogenic Differentiation 
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Cells were plated in Lab-Tek®II 4-Chamber glass slides (Figure 5-4) at a density of 
2500-3500 cells per cm
2
 (≈6000 cell/chamber) and incubated at 37° in a 5% CO2 
humidified incubator for 2 hours, then topped up with working medium.  
 
Figure ‎5-4: Seeding HDFs in 4-Chabber glass slides for adipogenic and osteogenic lineage 
differentiation. 
The medium was replaced every 3 days until the cells were 100% confluent. Upon 
reaching a state of confluency, the medium was replaced by Adipogenesis induction 
medium (STEMPRO
®
 Adipogenic Differentiation Kit- A10070-01) and this medium 
change is made reference to differentiation day 1. The adipogenic differentiation 
medium was changed every 2-3 days for up 21 days. Inverted phase microscopic 
monitoring for lipid droplets was performed every day for both test and control groups. 
At day 21 the medium was discarded and the cells were washed very gently with pre-
warmed PBS and then Oil-Red O staining was carried out.  
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Oil-Red O Staining 
Dye Preparation 
0.5g Oil-Red-O (Sigma # O0625) was dissolved in 100 ml Isopropanol (Fisher # 
P/7500/17) in a warm water bath to prepare stock solution.Three parts of Oil-Red-O 
stock solution were mixed with 2 parts of ultra-pure water to make the work solution. 
Staining 
The medium was removed and discarded. Cells were washed with PBS. Fixation was 
carried on through incubating the cells with 4% Paraformaldehyde for 30 minutes at 
room temperature. After discarding the fixing solution the cells were washed with PBS 
three times and then 0.5 ml ultra-pure water one time. 0.5 ml of Oil-Red-O working 
solution was added to the cells in each chamber and incubated for 50 minutes at room 
temperature. Removal of the dye was followed by gentle washing with ultra-pure water 
three times. 0.5 ml Hematoxylin was added to each chamber and incubated for 10 
minutes at room temperature. Hematoxylin was removed and cells were washed with 
ultra-pure water again. Stained cells were watched under inverted phase microscope and 
pictures were snapped.  
Osteogenic Differentiation 
Cell seeding was done with the same method described for adipogenic differentiation. 
After getting confluency the working medium was replaced with Osteogenesis induction 
medium (STEMPRO
®
 Osteogenic Differentiation Kit- A10072-01) and this medium 
change corresponded to differentiation day 1. The Osteogenesis differentiation medium 
was changed every 2-3 days for 21 days. Inverted phase microscopic monitoring was 
performed every day for both test and control groups. At day 21 the medium was 
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discarded and the cells were washed very gently with pre-warmed PBS and then 
Alizarin-Red staining was carried out. 
Alizarin-Red Staining 
Dye Preparation 
2.0 g Alizarin-Red (Sigma # A5533) was dissolved in 100 ml ultra-pure water and 
Filtered through a 0.45 µm filter paper. pH was adjusted to 4.2 using 10% Ammonium 
Hydrochloride. 
Staining 
After discarding the medium the cells were washed with PBS, and then fixed through 
incubating with 10% Formaldehyde for 30 minutes at room temperature. Fixative 
removal was followed by gentle washing with PBS three times and ultra-pure water one 
time. Addition of 1 ml Alizarin Red to each chamber was followed by incubation at 
room temperature for 30 minutes. The dye was removed and cells were washed with 
ultra-pure water three times, each time with gentle shaking for 5 minutes. Image 
acquisition was done after addition of 1 ml ultra-pure water.  
 
Chondrogenic Differentiation 
Small droplets of cell suspension were put in a centric order in previously medium 
coated 6-well plate (Figure 5-5) at a total density of 10
3
 cells per square cm and 
incubated.  
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Figure ‎5-5: Centric cell seeding for Chondrogenic Differentiation. 
Two hours later, 2 ml of chondrogenesis differentiation medium (STEMPRO
®
 
Chondrogenic Differentiation Kit- A10071-01) was added to each well and incubated. 
The Chondrogenesis differentiation medium was changed every 2-3 days for up to 21 
days. Inverted phase microscopic monitoring was performed every day for both test and 
control groups. At day 21, the medium was discarded and the cells were washed very 
gently with pre-warmed PBS and then Safranin O staining was carried out.  
Safranin-O Staining 
Cells were rinsed with PBS and then fixed with 10% Formaldehyde for 30 minutes at 
room temperature. Washing the cells with ultra-pure water was followed by putting 2 ml 
1.5% aqueous Safranin-O for 40 minutes. The dye was removed and cells were washed 
with ultra-pure water three times. 2 ml of 0.02% alcoholic fast green was added and 
removed after 30 seconds. 2 ml of 1% acetic acid was added and removed after 3 
seconds and cells were rinsed quickly with ultra-pure water and watched under an 
inverted phase microscope.  
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5.2.6.3 Immunologic Differentiation 
Flowcytometry 
Cryopreserved HDF cells at P6 were used for flowcytometry. Bovine Aortic Endothelial 
Cells (BAECs) were used as negative control. Immediately after thawing the cell 
suspension was diluted with fresh pre-warmed complete work medium and centrifuged 
at 220 rpm for 5 minutes. The supernatant was discarded and the cell pellet was 
resuspended in 1ml fresh medium. Cell count was performed through Trypan Blue and 
Haemocytometer chamber method. Cells were washed with 15 ml of wash medium 
(0.5% Bovine Serum Albumin [aMReSCO # 0332-25g] in PBS) and centrifuged at 
2000 rpm 5 minutes. The cell pellet was resuspended again in 12 ml wash medium and 
filtered through a 70 µM BD Falcon
TM
 nylon cell strainer [REF 352350]. Filtered cells 
were counted again and then divided into three separate tubes along with one tube for 
BAECs, each containing ≥106 cells and incubated on ice at 4°c for 20 minutes. After 
centrifuging at 2000 rpm for 5 minutes, the supernatants were discarded. The BAECs 
sample as the negative control and one of the HDF tubes were planned to be stained 
with CD90 (Anti-Fibroblast Antigen Mouse monoclonal Antibody) (AS02) 
[Calbiochem® # CP28] as the primary antibody. The second HDF tube was aimed to be 
stained with FITC conjugated CD31 CO.3E1D4 IgG2a antibody [GeneTex # 
GTX43622] as the negative control-2 and the last HDF was meant to remain unstained. 
The BAEC negative control-1and HDF Sample were resuspended respectively in 85 µl 
of sheath fluid [BD FACSFlow
TM
 # 342003] + 3 µg/15 µl of CD90. The HDF negative 
control-2 cells were resuspended in 90 µl of sheath fluid + 10 µl of CD31, and the last 
HDFs were resuspended in 100 µl of sheath fluid. All tubes were incubated at room 
temperature for 45 minutes. (Saalbach et al., 1996; Saalbach, Aust, Haustein, Herrmann, 
& Anderegg, 1997) After removing the primary antibody, cells were washed two times 
with sheath fluid and centrifuged at 2000 rpm 5 minutes. BAEC negative control-1and 
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HDF Sample were resuspended in 90 µl of Sheath fluid and 10 µl of Cy5 conjugated 
Goat Anti-Mouse IgG Secondary Antibody [Thermo SCIENTIFIC # PA1 -28523], 
wrapped in Aluminium foil and incubated for another 45 minutes at room temperature. 
After washing out the secondary antibody all samples were centrifuged at 2000 rpm and 
resuspended in 500 µl of sheath fluid and taken for flowcytometry. The final evaluation 
was done by using the FACS CANTO II.  
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QPCR 
In the present study, two fibroblast specific markers along with four stemness markers 
were used for fibroblast characterization through gene expression. Table 3-1 shows the 
particulars of different gene assays used for QPCR. 
Table ‎5-1: TaqMan® assays used for characterization of human dermal fibroblasts through gene 
expression 
Markers Gene name Abbrev. NCBI Ref. Seq. Assay No. 
Endogenous 
Control  
Glyceraldehyde 3-phosphate 
dehydrogenase 
GAPDH NM_001256799.1 Hs02758991_g1 
Fibroblast Markers Fibroblast Specific Protein 1 S100A4 NM_002961.2 Hs00243202_m1 
 Fibroblast Surface Antigen THY1 NM_006288.3 Hs00264235_s1 
Stemness Markers Octamer-binding transcription factor OCT4 NM_001173531.1 Hs04260367_gH 
 Sex Determining Region Y-Box 2 SOX2 NM_003106.3 Hs01053049_s1 
 NANOG NANOG NM_024865.2 Hs04260366_g1 
 Rex1 ZFP42 NM_174900.3 Hs01938187_s1 
 
 Fibroblast-specific protein 1 (FSP1) is a cyto/nucleoplasmic and extracellular 
calcium-binding protein that is encoded by S100A4 gene. FSP1 is assumed as a 
fibroblast marker in different organs (Österreicher et al., 2011; Strutz et al., 1995).  
 Fibroblast surface antigen, known also as CD90 and Thy-1 (thymocyte 
differentiation antigen 1) is a heavy cell surface protein which is encoded by THY1 
gene. In humans, Thy-1 is expressed by endothelial, smooth muscle, some of bone 
marrow cells, and also of fibroblasts of most vertebrate species studied (Saalbach et al., 
1997; Vaheri et al., 1976).  
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 OCT4 is a protein encoded in human by POU5F1 gene and is involved in the 
self-renewal of undifferentiated embryonic stem cells. 
 Sex Determining Region Y-Box 2 (SOX2) is a transcription factor responsible 
for pluripotency of stem cells.  
 NANOG is also a transcription factor in embryonic stem cells and is responsible 
for maintaining the pluripotency and self-renewal.  
 REX1 is protein encoded by ZFP42 gene and is responsible for maintaining the 
pluripotency of mesenchymal stem cells.  
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5.3 Results 
5.3.1 HDF Cell Morphology 
Fibroblast cells are known for their spindle shape morphology. Although they bear 
irregular round shapes when suspended, they start spreading when attaching on plastic 
surfaces. They align parallel while featuring wavy whirling arrangements in confluent 
states (Figure 5-6).  
 
Figure ‎5-6: Daily serial micrographs [form A) Day 0 to L) Day 11] of HDFs seeded on tissue culture 
polystyrene at an initial density of 3x10
3
/cm
3
. 
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Confocal laser scanning micrographs of HDFs in 3D culture on CMD porous scaffolds 
also shows their spindle-shaped morphology (Figure 5-7: B). FESEM micrograph of a 
spreading HDF cells with its cell processes is shown in Figure 5-7: C. 
 
Figure ‎5-7: Representative figures of human dermal fibroblasts: A) Typical spindle-shaped 
morphology of HDF cells in monolayer culture on TCP, B) 3D culture on CMD porous scaffold 
stained with Live-Dead assay, and C) FESEM micrograph of a single HDF cell spreading its 
processes and attaching on CMD surface. 
 
5.3.2 HDF Resazurin Standard Curves 
Four (4) Hour HDF Cell Attachment on TCP 
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Cell attachment on tissue culture polystyrene plates four hours after seeding 2-
100X10
3
HDFs was found to be 35.9±7.8% (Figure 5-8). Based on this data, the 
Resazurin standard curves were plotted on the basis of the number of the attached cells 
rather than the seeded density. 
 
Figure ‎5-8: Representative inverted microscope images of HDF cells seeded on TCP at varying 
densities of: A) 2x10
3
, B) 6X10
3
, C) 2x10
4
, D) 5x10
4
, and E) 10
5
 cells per well 4 hours after seeding. 
The graph F plots the harvested cell number 4 h after seeding against the initial seeding density 
(n=8 for each cell density). 
HDF cell number quantification in a wide incubation time and cell density range was 
feasible through AlamarBlue®/Resazurin dye diluted with either PBS or Phenol-red-
free DMEM.  
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Our data did not follow a normal distribution pattern. As such, Kruskal-Wallis Test was 
conducted and revealed no statistically significant difference in % reduction of the dye 
among four different formulations at each cell seeding density (P > 0.05). 
When % reduction in AlamarBlue
®
-DMEM was plotted against the cell number at 
different incubation time points the standard curve remained linear with correlation 
coefficients almost above 0.95 except for 1 and 4 hours (0.62 and 0.82 respectively), 
while regression lines showed overlappings at 1 and 2 hours and at 3 and 4 hours, and 
also dislocations at 3, 4, 6, and 12 hours (Figure 5-9). 
 
 
Figure ‎5-9: Reduction of AlamarBlue-DMEM as function of cell density in monolayer culture at 
varying incubation times from 1 to 22 hours. 
 
The correlation obtained between % reduction in AlamarBlue
®
-PBS and cell number at 
different incubation time points remained linear with correlation coefficients almost all 
above 0.95 except for 1, 6 and 22 hours, which were 0.75, 0.91, and 0.89 respectively, 
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while regression lines showed overlapping at 1 and 2 hours and at 4 and 6 hours, and 
also dislocations at 2, 5, and 12 hours (Figure 5-10).  
 
Figure ‎5-10: Reduction of AlamarBlue-PBS as function of cell density in monolayer culture at 
varying incubation times from 1 to 22 hours. 
 
Plotting % reduction in Resazurin-DMEM versus cell number at different incubation 
time points showed linear correlation with coefficients almost above 0.94 except for 1, 
3, 4, and 6 hours (0.83, 0.83, 0.85 and 0.92 respectively), while regression lines showed 
overlappings at 3 and 4 hours and at 5 and 6 hours, and also dislocation at 4, 6, and 14 
hours (Figure 5-11). 
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Figure ‎5-11: Reduction of Resazurin-PBS as function of cell density in monolayer culture at 
varying incubation times from 1 to 22 hours. 
The correlation between % reduction in Resazurin diluted in PBS and cell number at 
different incubation time points remained linear with correlation coefficients all above 
0.95 with almost no significant overlapping or dislocation (Figure 5-12). 
 
Figure ‎5-12: Reduction of Resazurin-PBS as function of cell density in monolayer culture at 
varying incubation times from 1 to 22 hours. 
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The Friedman Test showed a significant difference between all the first 5 time points at 
every given cell density in the Resazurin-PBS group (P < 0.05) (Figure 5-13). 
 
Figure ‎5-13: Resazurin Reduction Nomogram as a practical tool for quantification of Human 
Dermal Fibroblasts cell density in monolayer culture at 1 to 5 hours incubation times. The orders of 
all 5 curves look reasonable and logical. 
 
Our results confirm that the % reduction in Resazurin/ AlamarBlue® has a linear 
correlation with HDF cell number and that there is no statistically significant difference 
between the two different commercial dyes regardless of the dye preparation 
formulation is. Although there was no significant difference in the % reduction of the 
dye among four different formulations at every cell density, however, considering the 
correlation coefficients, the order and the regularity of the curves, Resazurin-PBS 
reduction nomogram is suggested as a practical graphic tool for determination of HDF 
cell number at different incubation times from 1-5 hours (Figure 5-13).  
The linearity of the correlation between the Resazurin reduction and HDF cell number 
appears to support the previous findings (Al-Nasiry, Geusens, Hanssens, Luyten, & 
Pijnenborg, 2007; Voytik-Harbin et al., 1998; Yu et al., 2003). Although our findings 
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showed similar features to the previous studies, however, the wide dye concentration as 
well as the cell density and type in our study are the advantages of our results. 
The correlation between the Resazurin dye absorption and the cell number has been 
studied with different cell types. AlamarBlue® dye has been shown to have a good 
constant correlation with Swiss 3T3 Mouse Fibroblast cell number in a wide range of 
dye concentration and cell density(Voytik-Harbin et al., 1998). The correlation between 
the optical density of AlamarBlue® dye and Retinal Pigment Epithelial Cell number has 
been reported to be linear with a correlation coefficient of 0.951 through absorbance 
method at 2, 4, 6, 9, 12, and 24 hour time points(Yu et al., 2003), and eventually 
plotting the AlamarBlue® % reduction against the logarithm of choriocarcinoma cell 
density (16.6– 500 X 103) was also reported to be linear with regression coefficients of 
0.73 – 0.81(Al-Nasiry et al., 2007).  
Although comparison between the four different dye formulations showed no significant 
difference between the four formulations at any given cell density, the correlation 
graphs look quite different in terms of the order of the curves and their correlation 
coefficients (Figure 5-12). As mentioned in the results section, several curve 
displacements and overlappings can be seen in both AlamarBlue® groups while curves 
in both Resazurin groups are more regular, with less overlapping/displacements. 
Correlation curves in Resazurin-PBS group look even more attenuable. Instructions 
from different companies generally recommend 2 to 4 hours of cell-dye incubation. Our 
results also show the lowest correlation coefficients for the 1
st
 hour of incubation 
(0.62≤R2≤0.83) among all groups except for the Resazurin-PBS group (R2=0.95).  
Although the correlations between % reduction in Resazurin diluted in PBS and cell 
concentrations at different incubation time points were high-R
2
 linear, the nomogram 
was modified, summarized and focused on the first 5 hours of incubation as most 
researchers prefer shorter incubation times.  
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All in all, Resazurin-PBS shows the best graph in terms of order, accuracy, and 
correlation coefficients. Our findings suggest the Resazurin-PBS reduction nomogram 
as the practical choice tool for determination of primary HDF cell number in monolayer 
cultures. HDF cell number can easily be determined with a high accuracy by having the 
% reduction of Resazurin at any incubation time between 1 to 5 hours using the 
suggested nomogram.  
5.3.3 DNA standard Curve 
The micro-plate readers are designed to present the data from serial dilutions of 
standard DNA in the form of a scatter graph plotting the relative fluorescence units 
against DNA concentration. In a short range between 1-50 µg/ml of DNA the regression 
line is linear with a high correlation coefficient. An R
2≥0.95 is usually acceptable 
(Figure 5-14).   
 
Figure ‎5-14: Plotting the relative fluorescence units (RFU) against the DNA concentration (µg/ml) 
yields a linear regression with high R2 value. This line is used as the DNA standard curve for 
quantification of DNA containing cell extracts. 
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5.3.4 HDF Cell Doubling Time 
Figure 5-6 depicts the daily serial inverted microscopic images of HDF cells seeded at a 
density of 3x10
3
 cells/cm
2
 on tissue culture polystyrene. As it can be seen in Figure 5-
15(A) HDF cells show a lag period of 2-3 days after seeding. The logarithmic phase 
starts at the 3
rd
 day and continues until 7-8
th
 day. 
 
Figure ‎5-15: Growth curves of HDF cells at P5 within 12 days culture based on A) cell count, B) 
DNA quantification, and C) percentage reduction in Resazurin. The lag, logarithmic and stationary 
phases are seen in graph A. 
5.3.5 Tri-lineage differentiation 
The adipogenic differentiation medium tends to induce stem cells to produce lipid 
vacuoles while having no effects on non-stem cells. Oil-Red-O staining of HDF cells 
fed with Adipogenic differentiation induction medium for two weeks showed few 
lipidification signs in HDF cells at passage 2 due to cell contamination with fat cells at 
low passages while no signs of lipidification in HDF cells at Passage 6. Human bone 
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marrow stem cells (HBMSCs) as the positive control cells showed lipid vacuoles after 
staining (Figure 5-16). 
 
Figure ‎5-16: Inverted microscope images of A) HBMSCs at P8, B) HDFs at P2, and C) HDFs at P6, 
all treated with adipogenic differentiation induction medium for two weeks and after Oil-Red-O 
staining showing the abundant lipid vacuoles in HBMSCs (A), rare vacuoles in HDF cells at low 
passage No. (B), and no evidence of lipid droplets in HDFs at passage 6 (C). 
Alizarin red staining of HDF cells at P2 and P6 and HBMSCs at P8 treated with 
osteogenic differentiation induction medium for two weeks shows vast calcification 
signs in HBMSCs and few in HDF cells at P2 while no signs of ossification are seen in 
HDFs at P6 (Figure 5-17).   
 
Figure ‎5-17: Alizarin-Red staining for Osteogenic differentiation shows numerous calcification 
signs in HBMSCs (A) and rare ossification signs in HDF cells at P2 (B), but no evidence of 
osteogenic differentiation in DHFs at P6 (C). 
Chondrogenic differentiation medium also failed to induce HDF cells to go through 
chondrogenesis. Figure 5-18 depicts Safranin-O stained HBMSCs (A) and HDF cells 
(B) both treated with chondrogenic differentiation induction medium for three weeks. 
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While HBMSCs show chondrogenic differentiation, no changes are seen in HDF cells 
toward chondrogenesis (Figure 5-18). 
 
Figure ‎5-18: Safranin-O staining of A) HBMSCs at P8 treated with chondrogenic differentiation 
induction medium for 3 weeks, and B) HDF cells at P6 with the same treatment. 
 The results of the tri-lineage differentiation test show that although HDF cells at low 
passages may show some weak evidences of lineage differentiation, which is due to the 
contamination with other cells, at higher proper passages they get more and more 
purified and do not show any evidence of lineage differentiation. 
5.3.6 Immunostaining 
5.3.6.1 FlowCytometry 
Flowcytometry graphs of HDF cells at passage 6 show a single cell population stained 
for CD90 as the fibroblast-specific marker. Non-stained cells were used as negative 
control, taking place in the 3rd quarter indicating that cells did not show any signal for 
CD90 marker (Figure 5-19-A). Cells positive for CD90 only were located in the Q4 
quarter (Figure 5-19-B). Figure 5-19-C also shows the histogram of cells stained with 
mouse monoclonal antibody to CD90. The X-axis of the histogram represents the signal 
value in channel numbers, while the Y-axis shows the number of events per channel 
number. Signals with identical intensities accumulate in the same channel. Therefore, 
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this histogram shows that the majority of events accumulated in the Cy5 channel and 
were positive for CD90. 
 
Figure ‎5-19: Flowcytometry scatter plots of HDF cells at P6 stained with Cy5 for CD90. A) 
unstained HDF cells as control were placed in 3
rd
 quarter, B) pure population of Cy5 stained HDFs 
for CD90 as the fibroblast-specific marker, C) Histogram of Cy5 as a single parameter. X axis 
represents the intensity of the signal in channel numbers while Y axis shows the quantity of the 
events per channel number. 
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5.3.7 Gene expression 
Results of gene expression profile of HDF cells are shown in Figure 5-20. The THY1 
gene, which is contains information for production of fibroblast specific antigen (FSA) 
was expressed twice much in HDF cells at P5 compared to HBMSCs (P8) and HADSCs 
(P0). The S100A4 gene encoding the data for fibroblast-specific protein 1 showed the 
same expression value in HBMSCs as in HDF cells but a much lower expression in 
HADSCs.  
Desmin expression in fibroblasts was much higher than HBMSCs, but almost the same 
in HADSCs. 
All four stemness markers (REX1, SOX2, NANOG, and OCT4) showed much higher 
expression values in both HBMSCs and HADSCs compared to HDF cells.  
 
Figure ‎5-20: Relative quantification of expression of fibroblast-specific marker and stemness genes 
in primary human dermal fibroblasts (HDF) at passage 5. Human bone marrow stem cells 
(HBMSC) at P8 and human adipose derived stem cells (HADSC) at P0 were used as controls. 
GAPDH has been used as the housekeeping gene. 
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Fibroblastic contamination in HADSCs used at P0 can be the reason for equal 
expression of Desmin in these cells with HDFs. On the other hand the expression of 
stemness genes in fibroblast populations is not supposed to be zero (Page et al., 2009).  
5.4 Discussion 
In this study we used the outgrowth technique for the isolation of HDF cell. Although 
the outgrowth method might seem a slower method, and it yields a lower recovery of 
cells compared to the enzymatic digestion methods, yet this provides the opportunity of 
multiple reuses of the skin explants for cell isolation. As compared to the enzymatic 
digestion method of cell isolation, the outgrowth method tends to isolate cells with a 
higher motility. When cell motility is a concern, especially when the cells are meant to 
be seeded on porous materials and the ability of cells to penetrate deep into the inner 
layers of the scaffolds is a matter of importance, the outgrowth method is the technique 
of choice for selecting the migrating cells (Rittié & Fisher, 2005). Moreover, even 
though the first isolation from freshly cut skin might take 2-3 weeks, the same skin 
pieces can be shifted to new culture dishes for the next course of isolation which will 
yield cells much faster (within 3-7 days). This process can be repeated several times, 
resulting in a high total cell yield.   
HDF morphology was confirmed through the use of inverted phase, confocal and 
scanning electron microscopes. Application of tri-lineage differentiation induction 
media proved the purity of HDF cell populations at proper passage (≥ 5th) and being free 
from stem cells. 
As an immunophenotyping test flowcytometry of HDF cells stained with Cy5 for CD90 
(THY1) as a fibroblast-specific cell surface protein confirmed the identity of the HDF 
cells.   
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The gene expression profile of HDF cells was also compared with that of two types of 
stem cells, which revealed that our HDF cell population is significantly different from 
stem cells. 
In conclusion, we managed to isolate a high motility pure population of human dermal 
fibroblasts which is perfectly suitable for tissue engineering application.   
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CHAPTER 6: CHONDROGENIC EFFECTS OF CMD SCAFFOLDS ON HDFs 
6.1 Introduction 
Cell-based therapies in cartilage tissue engineering take advantage of highly 
interconnected porous scaffolds capable of providing enough surface area and space for 
cell attachment, proliferation, nutrient and waste exchange as well as extracellular 
matrix production and deposition. The material from which the scaffold is fabricated 
plays a key role in chondroinduction. Various types of hydrogels, polymers, and 
composites of different materials that can support cartilage matrix production have been 
tried. (Hutmacher, 2000; Lu et al., 2001; Moradi et al., 2013; Moutos & Guilak, 2008). 
It has been suggested that modified native extracellular matrix (ECM) may contain 
bioactive factors that can contribute to cell growth, migration, and chondrogenic 
differentiation(Badylak, 2002; Benders et al., 2013; Izadifar et al., 2012). Human (Q. 
Yang, Peng, Guo, Huang, Zhang, Yao, et al., 2008) and porcine (Cheng et al., 2009) 
articular cartilage ECM derived scaffolds have shown promising results with the use 
ofhuman adipose derived adult stem cells and canine bone marrow stem cells 
respectively, supporting the hypothesis that a scaffold derived absolutely from cartilage 
ECM can induce chondrogenesis. The source from which the matrix is derived is a big 
concern. Human sources cannot be practically reliable on a high throughput rout due to 
lack of abundance. Porcine derived products also have limitations due to religious and 
ethical considerations. Animal sources with high abundance but without ethical issues 
can be the solutions of choice. Preserving the integrity of native cartilage ECM 
components is a key factor in ensuring that the total capacity of bioactive factors 
responsible for chondrogenesis. For cartilage tissue engineering purposes, the scaffold is 
supposed to support the maintenance of chondrocytes or differentiation of other cells 
with chondrogenic potential.  
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In chapter 3 we presented the detailed process of fabrication, characterization and 
optimization of bovine articular cartilage matrix derived porous scaffolds for cartilage 
tissue engineering applications. We showed that UV and UVDHT treated 15% CMD 
scaffolds possessed optimal geometry and architecture. In this chapter we present the 
detailed methods of assessment for the chondrogenic effects of bovine articular cartilage 
matrix derived porous scaffolds on human dermal fibroblast cells. To assess the 
biocompatibility of the optimized CMD scaffolds HDF cell viability and proliferation 
were qualitatively and quantitatively assessed through serial Resazurin reduction, DNA 
quantification, and confocal laser scanning and field emission scanning electron 
microscopy images. The chondroinductive potential of the CMD scaffolds was assessed 
through serial relative quantification of the expression of the chondrogenic genes as 
well as the production of sulphated glycosaminoglycans. Also, changes in scaffold size 
and shape were quantified and the correlation between scaffold shrinkage and cell 
proliferation and chondrogenic differentiation was described. 
6.2 Materials and Methods 
6.2.1 Cell Seeding 
HDF cells at passage 4 were resuspended in Chondrogenic medium at a final density of 
10 x10
6
 ml
-1
. The Chondrogenic medium consisted of DMEM-HG supplemented with 
20% (v/v) FBS, 1% Penicillin-Streptomycin, 1% HEPES, 1% non-essential amino-
acids, 1% ITS+Premix, 50 µg/ml L-ascorbic acid, 40 µg/ml L-Proline, 10 nM 
Dexamethasone, 10 nM TGF-β3 (Cheng et al., 2009; Cheng et al., 2011; Q. Yang, Peng, 
Guo, Huang, Zhang, Yang, et al., 2008; Zheng et al., 2011). UV and UVDHT treated 
CMD scaffolds (n=17 for each group at every time point) were pre-wetted with 50 μl of 
chondrogenic medium and incubated in a 37°C humidified 5% CO2 incubator for 15 
minutes. 50 μl of HDF cell suspension (5 x 105 cells) was gently seeded on each 
scaffold. The scaffolds were incubated in a 37°C humidified 5% CO2 incubator for 3 
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hours, then topped up very gently with 1 ml of pre-warmed fresh chondrogenic medium. 
Chondrogenic medium was changed every two days. Cell viability tests, scanning 
electron microscopy for cell-matrix interaction study, and biochemical and molecular 
analyses were performed at Day 2, 8, 15, 22, 29, 35, and 42 time points.  
6.2.2 Cell Growth and Viability 
Cell viability was determined using LIVE/DEAD
®
 Viability/ Cytotoxicity Kit 
(Invitrogen, UK). 1 μl of Calcein AM (4mM in anhydrous DMSO) added to2.5 μl of 
Ethidium homodimer (2mM in DMSO/H2O 1:4 (V/V) (Molecular probes
®
 - 
Lifetechnologies
™
, USA) were diluted in 1 ml pre-warmed 37ºC PBS. At every weekly 
time point one out of each seeded scaffold groups (UV and UVDHT) underwent 
staining through incubation with 500 μl of the diluted dye solution at 37ºC, 5% CO2 for 
45-60 mins prior to imaging.  
Imaging was performed with green fluorescence at ex/em ~495 nm/~515 nm for live 
cells and red fluorescence at ex/em ~495 nm/~635 nm for dead cells using a confocal 
laser scanning microscope (Leica TCS SP5 II, Germany). 
6.2.3 Cell Proliferation 
Cell proliferation was assessed via the Resazurin reduction assay (Dienstknecht et al., 
2010; Voytik-Harbin et al., 1998; Yu et al., 2003). At days 2, 8, 15, 22, 29, 35, and 42 
the seeded and non-seeded CMD scaffolds (n=16 for each group including the unseeded 
control sample) were incubated (37°c, 5% CO2) with 1 ml of pre-warmed 10% 
Resazurin in PBS for four hours. The absorbance was measured by a plate reader 
(FLUOstar OPTIMA BMG LABTECH, Germany) at 570 nm and 595 nm. Percentage 
reduction in Resazurin was calculated using the manufacturer defined formula (Gang et 
al., 2004). 
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6.2.4 Cell-scaffold Interaction Studies 
The seeded scaffolds were preserved in 2.5% Glutaraldehyde and underwent 
dehydration in a graded ethanol series (25%, 40%, 60%, 80%, 95% and 100%, each for 
30 min), followed by freeze-drying overnight. The freeze-dried samples were then 
coated with gold-palladium (Quorum, Q150R s) and scanned using a Quanta
TM
 250 
FEG – FEI microscope for cell-scaffold interaction studies. 
6.2.5 DNA Quantification 
Scaffolds (n≥5) were subjected to Papain digestion as described elsewhere (Caroline D. 
Hoemann, 2004; Moradi, Pramanik, Ataollahi, Abdul-Khalil, et al., 2014). Briefly, 
scaffolds were digested by incubating in 1 ml of Papain digest buffer (0.01 M L-
cysteine, 0.01M Na2EDTA, and 0.125 mg/mL papain in 0.1M sodium phosphate buffer) 
for overnight at 65°c with intermittent agitations. After precipitating the remaining 
debris, the digest solution was analysed for DNA content using Hoechst 33258 dye(0.1 
µl.ml
-1
 in TEN buffer) with calf thymus DNA(Sigma D1501) as standard. Plate reading 
was performed at (ex/em ~355 nm/~460 nm) in a microplate reader (FLUOstar 
OPTIMA BMG LABTECH, Germany). 
6.2.6 Construct Shrinkage and Contraction 
A separate 48 well plate with seeded and non-seeded UV and UVDHT treated scaffolds 
(n=7 for seeded and n=5 for non-seeded) was used for shrinkage test. Sterile plastic 
discs with known constant diameter of 9 mm were used as the scales (Figure 6-1). All 
scaffolds were treated with the same media exactly like the other plates. The media 
were removed every other day for quantification of sulfated glycosaminoglycan (GAGs) 
production using a 1,9-dimethylmethylene blue (DMMB) assay (Sigma, USA). Digital 
images of top views of the plate were captured after discarding the medium and were 
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analysed the by ImageJ® software for cross-sectional surface area changes. The plastic 
discs were used for setting the scales in each picture in ImageJ®. 
 
 
Figure ‎6-1: Scaffold shrinkage test after HDF cell seeding at different time points was tested by 
measuring the cross-sectional surface area of the scaffolds. Plastic white discs with known constant 
diameter were used for setting the scale in each picture. 
Total shrinkage was calculated by dividing the cross-sectional surface area at each time 
point to that of the original scaffold: 
𝑇𝑜𝑡𝑎𝑙 𝑆ℎ𝑟𝑖𝑛𝑘𝑎𝑔𝑒 (%) = 100 − (
𝑐𝑟𝑜𝑠𝑠 𝑠𝑒𝑐𝑡𝑖𝑜𝑛𝑎𝑙 𝑠𝑢𝑟𝑓𝑎𝑐𝑒 𝑎𝑟𝑒𝑎
𝑜𝑟𝑖𝑔𝑖𝑛𝑎𝑙 𝑐𝑟𝑜𝑠𝑠 𝑠𝑒𝑐𝑡𝑖𝑜𝑛𝑎𝑙 𝑠𝑢𝑟𝑓𝑎𝑐𝑒 𝑎𝑟𝑒𝑎
∗ 100) 
To determine the cell-mediated contraction (CMC) the contraction of seeded scaffolds 
was minused from that of non-seeded controls (C. Lee et al., 2001; Schulz Torres, M 
Freyman, Yannas, & Spector, 2000).  
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𝐶𝑀𝐶 = (
𝑜𝑟𝑖𝑔𝑖𝑛𝑎𝑙 𝑡𝑜𝑝 𝑠𝑢𝑟𝑓𝑎𝑐𝑒 𝑎𝑟𝑒𝑎 − 𝑡𝑜𝑝 𝑠𝑢𝑟𝑓𝑎𝑐𝑒 𝑎𝑟𝑒𝑎
𝑜𝑟𝑖𝑔𝑖𝑛𝑎𝑙 𝑡𝑜𝑝 𝑠𝑢𝑟𝑓𝑎𝑐𝑒 𝑎𝑟𝑒𝑎
)
𝑆𝑒𝑒𝑑𝑒𝑑
− (
𝑜𝑟𝑖𝑔𝑖𝑛𝑎𝑙 𝑡𝑜𝑝 𝑠𝑢𝑟𝑓𝑎𝑐𝑒 𝑎𝑟𝑒𝑎 − 𝑡𝑜𝑝 𝑠𝑢𝑟𝑓𝑎𝑐𝑒 𝑎𝑟𝑒𝑎
𝑜𝑟𝑖𝑔𝑖𝑛𝑎𝑙 𝑡𝑜𝑝 𝑠𝑢𝑟𝑓𝑎𝑐𝑒 𝑎𝑟𝑒𝑎
)
𝑁𝑜𝑛−𝑠𝑒𝑒𝑑𝑒𝑑
 
6.2.7 GAGs Quantification 
The sulfated glycosaminoglycan (GAGs) content in medium (n≥15) and the papain 
digested samples (n≥5) was assessed using a Dimethyl-methylene blue (16mg.ml-1) 
assay with a chondroitin-4-sulfate standard as described elsewhere (Caroline D 
Hoemann, 2004). Absorbance reading was performed at ex~595 nm in a miroplate 
reader. 
6.2.8 Gene Expression 
6.2.8.1 RNA Isolation 
RNA isolation from seeded scaffolds was done using Tri-Reagent
®
 solution 
(Lifetechnologies
™
 #AM9738) and according to the instructions from the 
manufacturer(Biosystems, 2008). The scaffolds were gently washed with PBS and 
transferred to 1.5 ml microcentrifuge labelled tubes. Mechanical shredding and 
homogenization of the scaffolds were done using pestles in 1.5 ml micro-centrifuge 
tubes. 500 ul Chloroform (Fisher # BP 1145-1) was added to each tube, vortex-mixed, 
and incubated at room temperature for 15minutes, followed by centrifugation at 12000 
RCF, 4°C, 15 min. The upper clear layer containing RNA (250 ul) was transferred to a 
new tube and the two remaining lower layers containing DNA were frozen @ -80 in the 
same tube for further DNA quantification through Hoechst assays. 500 ul Isopropanol 
(Sigma # I9516) was added to the RNA and vortex mixed, and then incubated at room 
temperature for 5minutes. Centrifugation was performed at 12000 RCF, 4°C, for 10 
min. The supernatant was discarded. 1 ml of 75% Ethanol (prepared from absolute 
Ethanol and Ultra-Pure distilled RNAse/DNAse-free water) was added to each RNA 
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pellet, vortex-mixed, and incubated at room temperature for 5minutes. Centrifugation at 
7500 RCF, 4°C, for 5 min was followed by removal of supernatant Ethanol. The RNA 
pellet was re-suspended in 20 ul Ultra-Pure distilled RNAse/DNAse-free water 
(Invitrogen # 10977), vortex-mixed and subjected to RNA quantification using the 
Nanodrop ND2000 (Thermo Scientific).  
6.2.8.2 cDNA Synthesis 
cDNA synthesis was done using the High-Capacity RNA-to-cDNA
™
 Kit (Applied 
Biosystems # 4387406). Up to 2000 ng of RNA from each sample plus Ultra-Pure 
distilled RNAse/DNAse-free water, collectively to a total volume of 9 μl was 
transferred to a 0.2 ml PCR tube, and topped up with 10 µl of 2X RT Buffer Mix 
(includes dNTPs, random octamers, and oligo dT-16) and finally 1 μl of 20X Enzyme 
mix (MuLV and RNase inhibitor protein). RT- PCR was performed using a MyGene 
Series Peltier Thermal Cycler Model MG96G. 
6.2.8.3 TaqMan® Gene Assays 
Collagen, type 1, alpha 1, provides genetic information for the construction of the type 1 
collage macromolecule that is the most abundant form of collagen in the human body 
and acts as the supporting and strengthening of tissues like bone, tendon, cartilage and 
skin. Molecular location of this gene is on the long arm of chromosome 17(National 
Library of Medicine, 2014b).  
Triple-stranded rope-like procollagen macromolecules are composed of two pro-alpha 
1(I) and one pro-alpha 2(II) (encoded by COL1A2 gene) chains that twist together. 
Processed procollagens make mature collagen molecules which auto-arrange and form 
long thin collagen fibrils. Cross-linkage of these thin fibrils results in formation of 
extracellular strong collagen I fibrils(National Library of Medicine, 2014c). 
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Located on chromosome 12, “collagen, Type 2, alpha 1” gene, also known as COL2A1 
is responsible for encoding the production of pro-alpha 1(II) chain, a subcomponent of 
collagen type II which is primarily found in cartilage tissue. It is also found in the 
vitreous (eyeball gel), the inner ear and the nucleus pulposus (the central part of the 
inter-vertebrate disc).Mutations in COL2A1 gene have been shown to cause defective 
collage type II and end up with several disorders(National Library of Medicine, 2014d). 
Aggrecan, the most abundant proteoglycan in the cartilage, is a protein with several 
adjunct sugar molecules. Attaching to the other components of cartilage, Aggrecan 
organizes and reinforces molecular network within the cartilage. The gel-like structure 
of cartilage comes from the water molecules attached to the sugar part of Aggrecan. The 
gene that contains the information for production of Aggrecan in called ACAN, a 
member of PG family of genes(National Library of Medicine, 2014a).  
Proteoglycan 4 is a large protein synthesised specifically by the superficial 
chondrocytes of the articular cartilage acting as a boundary lubricant at the cartilage 
surface. The protein is encoded by PRG4 gene located on the long arm of chromosome 
1(National Library of Medicine, 2014e). 
SOX9 is the official symbol for SRY (sex determining region Y)-box 9 gene which 
provides instructions for production ofSOX9 protein that plays a critical role in 
development of the skeleton and reproductive system during the embryonic term. The 
protein acts as a transcription factor binding to specific regions of DNA and regulating 
the activity of other genes. It acts as a transcription factor for the HMG (high mobility 
group) domain expressed in cartilage cells. SOX9 gene is expressed in cartilage 
coincidentally with COL2A1 gene(Bell et al., 1997). SOX9 protein binds to and 
activates the essential chondrocyte-specific enhancer sequences in non-chondrocytic 
cells(Veronique Lefebvre, Huang, Harley, Goodfellow, & de Crombrugghe, 1997; Ng et 
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al., 1997; Wright et al., 1995; Zhao, Eberspaecher, Lefebvre, & de Crombrugghe, 
1997). 
Cartilage oligomeric matrix protein encoded by COMP gene on chromosome 19 is one 
of the calcium-binding proteins found in the ECM spaces surrounding chondrocytes. It 
has been shown that COMP enhances matrix assembly during chondrogenesis of human 
mesenchymal stem cells (Haleem‐Smith, Calderon, Song, Tuan, & Chen, 2012; Kipnes 
et al., 2003). 
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Table ‎6-1: TaqMan® Assay Probes Used in QPCR. 
Gene name Abbrev. Transcript 
Variant 
NCBI Ref. Seq. Assay No. 
Collagen I Col1A1  NM_000088.3 Hs00164004_m1 
Col1A2  NM_000089.3 Hs00164099_m1 
Collagen II Col2A1 1 NM_001844.4 Hs00264051_m1 
2 NM_033150.2 
Cartilage 
Oligomeric Matrix 
Protein 
COMP  NM_000095.2 Hs00164359_m1 
Sex Determining 
Region Y-Box 9 
SOX9  NM_000346.3 Hs01001343_g1 
Aggrecan ACAN 1 NM_001135.3 Hs00153936_m1 
2 NM_013227.3 
Proteoglycan 4 PRG4 A NM_005807.3 Hs00981633_m1 
B NM_001127708.1 
C NM_001127709.1 
D NM_001127710.1 
Glyceraldehyde 6-
Phosphate 
Dehydrogenase 
GAPDH 1 NM_002046.4 Hs02758991_g1 
  2 NM_001256799.1 
 
6.2.9 Gene Expression 
To assess the quantitative expression of each of the genes listed in table 1, triplicates of 
1 µl of cDNA sample were transferred to a 96 well PCR plate (MicroAmp® 
InduraPlate™, Applied Biosystems®), topped up with 10 µl of TaqMan® master mix, 8 
µl of Nuclease-free water, and 1 µl of the target/housekeeping gene (TaqMan® Assay). 
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The plate was sealed with adhesive film (MicroAmp®, Applied Biosystems®). QPCR 
was performed using a StepOnePlus™ Real-Time PCR System - Life Technologies.  
Relative quantification (RQ) of expressed genes was calculated from threshold cycle 
(Ct) values using the following formula: 
𝑅𝑄 = 2−(∆𝐶𝑡𝑇𝑎𝑟𝑔𝑒𝑡 − ∆𝐶𝑡𝑅𝑒𝑓𝑒𝑟𝑒𝑛𝑐𝑒) 
Where: 
∆𝐶𝑡𝑇𝑎𝑟𝑔𝑒𝑡 = 𝐶𝑡𝑇𝑎𝑟𝑔𝑒𝑡𝑇𝑎𝑟𝑔𝑒𝑡 𝐺𝑒𝑛𝑒 − 𝐶𝑡𝑇𝑎𝑟𝑔𝑒𝑡𝐻𝑜𝑢𝑠𝑒𝑘𝑒𝑒𝑝𝑖𝑛𝑔 𝐺𝑒𝑛𝑒  
And: 
∆𝐶𝑡𝑅𝑒𝑓𝑒𝑟𝑒𝑛𝑐𝑒 = 𝐶𝑡𝑅𝑒𝑓𝑒𝑟𝑒𝑛𝑐𝑒𝑇𝑎𝑟𝑔𝑒𝑡 𝐺𝑒𝑛𝑒 − 𝐶𝑡𝑅𝑒𝑓𝑒𝑟𝑒𝑛𝑐𝑒𝐻𝑜𝑢𝑠𝑒𝑘𝑒𝑒𝑝𝑖𝑛𝑔 𝐺𝑒𝑛𝑒  
 
6.2.10 FESEM 
The same samples used for confocal laser scanning microscopy were preserved after the 
scanning session in 2.5% Glutaraldehyde and underwent dehydration process in graded 
ethanol series (25%, 40%, 60%, 80% and 100%, each for 30 min), followed by freeze-
drying. The dry samples were then coated with gold-palladium (Quorum, Q150R s) and 
scanned using a Quanta
TM
 250 FEG – FEI microscope for cell-scaffold interaction 
studies. 
6.3 Results 
6.3.1 Resazurin Reduction 
Figure 6-2 depicts the results of percentage reduction in Resazurin absorption in HDF 
seeded UV and UVDHT treated CMD scaffolds. A steep increase was seen in Resazurin 
reduction in UV treated scaffolds during the first three weeks after cell seeding, 
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indicating of cell proliferation within the porous spaces of the scaffolds. This rapid rise 
was followed by a mild drop and the subsequent monotonic plateau resulting from the 
retardation in cell growth due to lack of space and cell-cell contact inhibition.    
 
Figure ‎6-2: Percentage reduction in Resazurin absorption in HDF seeded UV and UVDHT treated 
CMD scaffolds at different weekly time-points. 
Significant increases in Resazurin reduction (P<0.05) in UV group during the first three 
weeks of culture was indicating the cell proliferation which was followed by a drop in 
the fourth week followed by an almost constant trend up to the 6
th
 week. Resazurin 
reduction showed a milder steep during the first three weeks but the same steady trend 
during the rest of time points.   
6.3.2 Confocal laser scanning microscopy (CLSM) 
Serial CLSM graphs of HDF cells seeded on both groups of CMD scaffolds clearly 
illustrated the cell attachment and progressive proliferation and infiltration of the 
growing cells into and filling the pores of the porous scaffolds. Although cells seeded 
on UVDHT scaffolds showed a slower growth during the first 2 weeks, they reached the 
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same confluent state at third week as those seeded on UV treated CMD scaffolds. Both 
groups keep showing the same constant dense features in confocal images after the third 
week of culture. Cell morphology in both groups remained fibroblastic during the 
culture period (Figure 6-3&4).  
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Figure ‎6-3: Confocal laser scanning micrographs of HDF cells seeded on UV and UVDHT treated 
CMD scaffolds at different weekly time points. All images have been captured after staining with 
LIVE/DEAD® Viability/Cytotoxicity Kit (green for Calcein and red for Ethidium homodimer). 
(The scale bars in main and inset images represent for 200µm and 50 µm respectively). 
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Figure ‎6-4: Continued form Figure 6-3. 
6.3.3 DNA Quantification 
DNA quantification of papain digested scaffolds shows a sharp upward trend in the 
DNA content during the first three weeks after culture indicating an increasing 
proliferation of cells on both UV and UVDHT treated CMD scaffolds. The steep slope 
collapses after the third week to a mild decreasing trend. Shrinkage and contraction of 
the scaffolds diminishes the growth area and attenuates the cell proliferation.   
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Figure ‎6-5: Total DNA by Hoechst method in papain digested cell seeded UV and UVDHT treated 
CMD scaffolds (n=5 for each group) at different weekly time-points after subtraction of average 
DNA in unseeded (blank) samples. 
A two-way between-groups analysis of variances was conducted to determine the 
differences in Total DNA concentration between the two groups (cell seeded UV and 
UVDHT treated CMD scaffolds) at different time points. The significance value for 
Levene's test of homogeneity of variances was 0.066 (greater than 0.05), indicating that 
the assumption of homogeneity of variance has not been violated. 
Post-hoc comparisons using the Tukey HSD test indicated that although the DNA 
content was not significantly higher at Day8 compared to Day2, however, a significant 
increase in the DNA content happened at the 2nd and 3
rd
 weeks of culture, which was 
followed by a drop at the 4
th
 week which remained constant until the Day42 with 
another significant decrease. No significant difference was seen in the DNA content 
between the UV and UVDHT groups at different time points (P≥0.05). 
6.3.4 FESEM 
Serial FESEM micrographs of HDF seeded UV and UVDHT treated CMD scaffolds at 
weekly time points are shown in Figure 6-6&7. The first couple of images (A and A’) 
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are representative for the unseeded UV and UVDHT treated scaffolds, showing the 
wrinkled morphology of surfaces and filamentous structures of interconnected pores. 
Cell attachment and proliferation on all over the surfaces and inside the pores of both 
types of CMD scaffolds clearly shows the gradual growth and spreading of the cells, 
progressively filling all the spaces and covering the surfaces, resulting in entirely 
consistent cell-coated surfaces all over the constructs at Day22. FESEM images of the 
samples at any time point after Day22 show surfaces covered with intertwined visually 
inseparable cells.  
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Figure ‎6-6:‎ FESEM‎micrographs‎ of‎ unseeded‎ (A&A’)‎ and‎ cell‎ seeded‎ UV‎ and‎ UVDHT‎ treated‎
CMD‎ scaffolds‎ at‎ weekly‎ time‎ points‎ from‎Day‎ 2‎ (B&B’)‎ to‎ Day‎ 42‎ (H&H’).‎ The‎ scale-bar for 
image A is 100 µm while for the rest of the images they represent for 50 µm. 
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Figure ‎6-7: Continued for Figure 6-6. 
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6.3.5 Scaffold Shrinkage/Contraction 
Serial digital top images of representative scaffolds captured at weekly time points are 
shown in Figure 6-8. Decreases in the size of scaffolds, especially the seeded ones are 
clearly visible. Surface area measurements using ImageJ
®
 was applied to conduct a 
quantitative study.  
 
Figure ‎6-8: Serial digital images of top view of representative blank (unseeded) and HDF seeded 
UV and UVDHT treated CMD scaffolds at seeding time and consecutive weekly time points. The 
white circular plastic discs were used as the constant fixed-dimension scales. 
Figure 6-10 shows the average cross-sectional (top) surface area of dry, unseeded and 
seeded wet UV and UVDHT treated 15% CMD scaffolds (n=7 for seeded and n=5 for 
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unseeded scaffolds) at seeding time and different weekly time points. All wetted 
scaffolds either with cell suspension or equivalent volume of culture medium showed a 
slight non-significant (P>0.05) increase in the cross-sectional surface area immediately 
after wetting, which is expected due to the spongy nature of the scaffolds and the 
surface tension of the medium as demonstrated in Figure 6-9. 
 
Figure ‎6-9: Effect of wetting on the dimensions of porous spongy scaffolds. 
A two-way (between-groups) analysis of variances was conducted to determine the 
differences in cross-sectional surface area between the four groups (Seeded and 
Unseeded UV and UVDHT treated 15% CMD scaffolds) at different time points. Post-
hoc comparisons using the Tukey HSD test was used to find the differences between the 
different groups at different time points. A value of P≥0.05 was assumed as non-
significant. 
As the cells attached on the surfaces and inside the pores of the scaffolds, shrinkage 
started and the top surface area showed a rapid fall during the first three weeks 
concurrently with increasing proliferation of the cells as previously shown and 
confirmed in Resazurin reduction, DNA content, confocal laser microscopy and FESEM 
images. However, the sharp decrease in the surface area got tapered down after Day22 
of culture. Even unseeded scaffolds showed a downward trend of surface area, which 
slowed down and showed a mild slope after the Day8. This suggests that not all the 
shrinkage is cell induced and at least part of scaffold shrinkage results from scaffold 
contraction and degradation processes. Although the difference in cross-sectional 
149 
surface area of cell seeded UV and UVDHT treated 15% CMD scaffolds is not 
significant at different time points (P>0.05), however the significant difference between 
Unseeded UV and UVDHT treated 15% CMD scaffolds started from Day22 and 
onwards, showing a significantly bigger drop in the cross-sectional surface area of 
Unseeded UVDHT scaffolds compared to Unseeded UV treated scaffolds, reconfirming 
the higher stiffness of UV treated scaffolds. Although 15% UV and UVDHT treated 
CMD scaffolds have been shown to possess higher cross-linking among other CMD 
scaffolds, apart from the degradation effect, cell mediated contraction of the scaffolds is 
still shrinking the scaffolds in a significant scale.  
 
Figure ‎6-10: Measurements of cross-sectional surface area (top view) of the seeded and unseeded 
UV and UVDHT treated 15% CMD scaffolds (n=7 for seeded and n=5 for unseeded scaffolds. 
Significant and non-significant differences are shown‎by‎(*:‎P<0.05)‎and‎(†:‎P>0.0). 
Results of total shrinkage (%) and cell-mediated contraction (%) at different weekly 
time points are shown in Figure 6-11. A two-way between-groups analysis of variances 
was conducted to determine the differences in percentage shrinkage between the UV 
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and UVDHT treated 15% CMD scaffolds at different time points. Post-hoc comparisons 
using the Tukey HSD test was used to find the differences between the two groups at 
different time points. A value of P≥0.05 was assumed as non-significant.  
As it can be clearly seen HDF seeded UV treated CMD constructs show a sharp 
decrease in the size during the first three weeks after seeding but then reach a steady 
state with a gentle increase in shrinkage and contraction during the next four weeks. 
UVDHT treated CMD scaffolds continue their sharp rise in shrinkage until the fourth 
week of seeding and while cell-mediated contraction has a considerably weaker effect 
on UVDHT treated scaffolds they exert the same degree of total shrinkage in the size as 
UV treated scaffolds. 
Also, having considered the equal porosity among both group of scaffolds, although cell 
mediated contraction (CMC) in UV group is significantly higher due to a higher rate of 
cell proliferation compared to the UVDHT group in almost all time points, there is no 
significant difference in total shrinkage between the UV and UVDHT groups. The 
higher CMC in UV group is contemporaneous and legitimizable with the higher cell 
growth and proliferation in UV group shown in Resazurin reduction test results. The 
bigger CMC in UV group due to higher cell proliferation has been compensated by the 
higher stiffness, resulting in a total shrinkage rate similar to the UVDHT group with a 
proportionally lower cell proliferation as well as lower stiffness.   
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Figure ‎6-11: Percentage of total shrinkage in HDF seeded UV and UVDHT treated CMD scaffolds 
(n=7 for seeded scaffolds and n=5 for unseeded scaffolds) at different weekly time-points. Part of 
this shrinkage is due to cell mediated contraction (CMC). Asterix stands for P<0.05. 
6.4 Chondrogenic Differentiation 
6.4.1 GAGs Content 
Attempts to measure GAGs through DMMB method failed to show any GAGs in the 
medium up to Day42. This means that no significant amounts of GAGs either released 
from the scaffolds as a result of biodegradation or from the HDF cells seeded on the 
CMD scaffolds as their extracellular matrix production could be detected by DMMB 
method. 
Unlike the medium, Papain digested constructs at different weekly time points showed a 
good trend of GAGs accumulation within the cells. Figure 6-12 displays the GAGs 
content of papain digested cell seeded UV and UVDHT scaffolds after subtraction of 
average GAGs content in papain-digested unseeded samples (blanks). A peak in GAGs 
production in both groups is achieved within two weeks after cell seeding, followed by 
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a reduction in the third week and then a plateau, but always higher compared to the 
Day2. 
 
Figure ‎6-12: Sulfated Glycosaminoglycan content in cell seeded UV and UVDHT treated CMD 
scaffolds (n=5 in each group) at different weekly time points after subtraction of the average GAGs 
in unseeded samples, measured through DMMB method. 
When the GAGs production is plotted against shrinkage rate (Figure 6-13), the effect of 
available surface area and space for the cells to grow and deposit ECM molecules like 
GAGs is revealed more clearer. These results clearly demonstrate the HDF cells 
tendency to produce GAGs when they are seeded on CMD scaffolds, however, GAGs 
production slowed down coincidentally with the scaffold shrinkage. This trend suggests 
that scaffold shrinkage and contraction is a potential cause of the reduction in GAGs 
production. As demonstrated previously(Buckley et al., 2009; C‐Y Charles Huang, Paul 
M Reuben, Gianluca D'Ippolito, Paul C Schiller, & Herman S Cheung, 2004; R. Mauck, 
C. Wang, E. Oswald, G. Ateshian, & C. Hung, 2003b), increasing the proportional cell 
density favors chondrogenesis in terms of cartilage matrix production, but at a certain 
critical point when cells lack physical space, their growth and ECM producibility 
diminishes.  
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Figure ‎6-13: Correlation between sulfated glycosaminoglycan production and shrinkage rate in 
cells seeded on UV and UVDHT treated 15% CMD scaffolds. 
A similar correlation exists between the DNA content and the shrinkage rate of cell 
seeded UV and UVDHT treated CMD constructs (Figure 6-14), reconfirming the effect 
of scaffold shrinkage on proliferation pattern of cells seeded on these porous scaffolds.  
 
‎6-14: Correlation between total DNA and shrinkage rate in HDF-seeded UV and UVDHT treated 
15% CMD scaffolds. 
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6.4.2 QPCR 
Although an initial down regulation of COL1A1 gene was seen in Day 2 compared to 
the negative control HDF cells, the overall trend was increasing in both UV and 
UVDHT groups during the culture period with a significant higher expression (P<0.05) 
in UV group and up to 3-4 folds compared to the negative control. (Figure 6-15, A). 
COL1A2 gene showed an upward trend in both UV and UVDHT groups during the first 
3 weeks of culture, followed by a drop and the consequent plateau in both groups during 
the rest of the culture period (Figure 6-15, B). The expression of Col1A2 was 
significantly higher (P<0.05) in UVDHT group in all time points (P<0.05). 
COL2A1 as the cartilage specific gene clearly showed two phases of expression: an 
almost constant expression with even some mild down regulation during the first 2-3 
weeks, followed by the second phase with a sharp upregulation in both groups, with a 
significantly higher trend in UVDHT group (P<0.05). An overall increase up to over 
three and four folds in expression of COL2A1 was seen during the 7 weeks of culture in 
both UV and UVDHT groups (Figure 6-15, C).  
The expression of ACAN, the gene encoding the cartilage proteoglycan molecule, 
Aggrecan, clearly showed a drastically increasing trend in both groups with a 
significantly higher trend in UVDHT group compared to the negative control (Figure 6-
15, D). 
SOX9, the gene containing the data for production of the transcription factor for the 
high mobility group domain expressed in cartilage cells, and COMP gene which is in 
charge of matrix assembly enhancement during chondrogenesis, both showed sharp 
upward steeps during the first three weeks of culture, followed by a sharp drop in SOX9 
to a level even lower that negative control, while an almost steady state for COMP but 
still much higher than the negative control (Figure 6-15, E and F). 
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Figure ‎6-15: Quantitative gene expression of COL1A1 in HDFs seeded on UV and UVDHT treated 
CMD scaffolds (n=7 in each group) at weekly time points. The data have been normalized to 
GAPDH. HDF cells were used as Ctrl
-
 . 
6.4.2.1 Scaffold Shrinkage/Contraction 
Serial digital top images of representative scaffolds captured at weekly time points are 
shown in Figure 6-16, A. Decreases in the scaffold sizes during the time, especially in 
the seeded ones are clearly visible. Surface area measurements using ImageJ
®
 was 
applied to conduct a quantitative study.  
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Figure ‎6-16: A) Serial digital images of top view of representative blank (unseeded) and HDF 
seeded UV and UVDHT treated CMD scaffolds at seeding time and consecutive weekly time points. 
The white circular plastic discs were used as the constant fixed-dimension scales. 
B) Measurements of cross-sectional surface area (top view) of the seeded and unseeded UV and 
UVDHT treated CMD scaffolds (n=7 for seeded and n=5 for unseeded scaffolds). Significant and 
non-significant‎differences‎are‎shown‎by‎(*:‎P<0.05)‎and‎(†:‎P>0.0). 
C) The initial effect of wetting on the dimensions of porous spongy scaffolds. 
D) Percentage of total shrinkage in HDF seeded UV and UVDHT treated CMD scaffolds (n=7 for 
seeded scaffolds and n=5 for unseeded scaffolds) at different weekly time-points. Part of this 
shrinkage is due to cell mediated contraction (CMC). Asterix stands for P<0.05. 
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Figure 6-16, B shows the average cross-sectional (top) surface area of dry, unseeded 
and seeded wet UV and UVDHT treated 15% CMD scaffolds (n=7 for seeded and n=5 
for unseeded scaffolds) at seeding time and sequential weekly time points. Wetted 
scaffolds, either with cell suspension or equivalent volume of culture medium, showed a 
non-significant (P>0.05) increase in the cross-sectional surface area immediately after 
wetting. This may be due to the hydrophilic spongy nature of the scaffolds and the 
surface tension of the medium compressing the scaffold, resulting in a light decrease in 
the height and a simultaneous slight increase in the top surface area as demonstrated in 
Figure 6-16, C. 
As the cells attached on the surfaces and inside the pores of the scaffolds, shrinkage 
increased and the top surface area showed a rapid fall during the first three weeks 
concurrently with increasing proliferation of the cells as previously shown and 
confirmed in DNA content, confocal laser microscopy and FESEM images. However 
the sharp decrease in the surface area got tapered down after Day22 of culture. 
Unseeded scaffolds showed a downward trend of surface area during the first week of 
immersion in the culture medium, which slowed down and showed a mild slope after 
Day8. This suggests that not all the shrinkage is cell induced and at least part of scaffold 
shrinkage results from scaffold contraction and degradation processes. Although the 
difference between the cross-sectional surface area of seeded UV and UVDHT scaffolds 
was not significant at different time points (P>0.05), however a significant difference 
between Unseeded UV and UVDHT scaffolds started from Day22 and onwards, 
showing a significantly bigger drop in the cross-sectional surface area of Unseeded 
UVDHT scaffolds compared to Unseeded UV treated scaffolds, reconfirming the higher 
stiffness of UV treated scaffolds. Although 15% UV and UVDHT treated CMD 
scaffolds have been shown to possess higher cross-linking among other CMD scaffolds 
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(Moradi, Pramanik, Ataollahi, Abdul-Khalil, et al., 2014), cell mediated contraction of 
the scaffolds is still shrinking the scaffolds in a significant scale.  
Results of total shrinkage (%) and cell-mediated contraction (%) at different weekly 
time points are shown in Figure 6-16, D. As it can be clearly seen HDF seeded UV 
treated CMD constructs show a sharp decrease in the size during the first three weeks 
after seeding but then reach a steady state with a gentle increase in shrinkage and 
contraction during the next four weeks. UVDHT treated CMD scaffolds continue their 
sharp rise in shrinkage until the fourth week of seeding. While cell-mediated contraction 
has a considerably weaker effect on UVDHT treated scaffolds they exert the same 
degree of total shrinkage in the size as UV treated scaffolds. 
Also, having considered the equal porosity among both groups of scaffolds, there was 
no significant difference in total shrinkage between the UV and UVDHT groups.  
6.4.2.2 The correlation between the Shrinkage, Cell Proliferation and 
Chondrogenesis 
The correlation between COL2A1 and ACAN gene expression and the DNA content 
(Figure 6-17, A&B) clearly showed two distinct phases of gene expression during the 
42 days of cell culture. The first phase was determined by an increase in the DNA 
content with a plateau state of COL2A1 and ACAN genes expression within the first 2-
3 weeks of culture. The second phase was defined by a cessation in the DNA content 
and a simultaneous increase in the expression of COL2A1 and ACAN genes. The 
asynchronicity of cell proliferation with differentiation has already been addressed in 
other works (Strehl, Schumacher, de Vries, & Minuth, 2002; Topisirovic & Sonenberg, 
2014). Also, chondrogenic differentiation has been shown to be dependent on high cell 
density (Buckley et al., 2009; C‐Y Charles Huang et al., 2004; Mauck et al., 2003b). 
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During the first phase, cell proliferation provides the high density as a prerequisite for 
the second phase of differentiation. 
Plotting the DNA content as a function of cell proliferation against the shrinkage rate 
also showed a biphasic trend indicating that as the cells proliferate progressively, they 
contract and shrink the scaffolds accordingly until a certain critical point when a 
scarcity in the surface area and space leaves no sufficient room for cell proliferation 
(Figure 6-17, C). Beyond this critical point any further increases in the shrinkage was 
contemporaneous with a slump in cell proliferation. This finding was in agreement with 
the previous studies (C. Lee et al., 2001; Schulz Torres et al., 2000).  
The correlation between GAGs production and the shrinkage rate is presented in Figure 
6-17, D. The HDF cells clearly showed a tendency to produce GAGs when seeded on 
CMD scaffolds. GAGs production was drowsed off coincidentally with the scaffold 
shrinkage and contraction pattern. This trend suggests that scaffold shrinkage and 
contraction is a potential cause of the reduction in GAGs production. As addressed in 
other works increasing the proportional cell density favours chondrogenesis in terms of 
cartilage matrix production, but at a certain critical point when the cells face lack of 
enough space, their growth and ECM producibility diminishes (C‐Y Charles Huang et 
al., 2004; Mauck et al., 2003a).  
The correlation between the expression of COL2A1 and ACAN genes and the scaffold 
shrinkage (Figure 6-17, E & F) reconfirmed the biphasic trend of cell proliferation-
differentiation and revealed that the cell proliferation phase and the increasing shrinkage 
were concurrent with steady state of slow chondrogenic gene expression, but during the 
second phase the fast increasing expression of COL2A1 and ACAN genes was 
simultaneous with an invariant shrinkage. 
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Figure ‎6-17: Correlation between A) COL2A1 and B) ACAN gene expression, and DNA content, C) 
the DNA and D) GAGs content, and E) COL2A1 and F) ACAN expression all against shrinkage 
rate. 
6.5 Discussion 
Chondrogenic potential of porcine(Cheng et al., 2009) and human(Q. Yang, Peng, Guo, 
Huang, Zhang, Yao, et al., 2008) CMD constructs on various stem cells has been 
previously investigated. It is also apparent, cell mediated contraction and shrinkage of 
non-treated and structurally enhanced matrix derived scaffolds and their effects on 
chondrogenesis have been studied in previous studies(Zaleskas et al., 2004). In this 
chapter we discussed the methods of evaluating the chondrogenic potential of 
structurally tailored and optimized bovine articular CMD porous scaffolds on cultured 
161 
primary human dermal fibroblasts as semi-differentiated cells of mesenchymal origin. 
The probability of cell mediated contraction and scaffold shrinkage in physically treated 
CMD scaffolds and their effects on chondrogenic differentiation of HDF cells were also 
investigated. 
Serial measurements of DNA content and Resazurin reduction as well as imaging 
techniques (CLSM and FESEM) demonstrated that physically treated bovine CMD 
scaffolds are suitable biocompatible constructs for HDF cell attachment and 
proliferation. This was a completely expected outcome as the main component of CMD 
scaffolds is collagen which has been shown to be a perfect biomaterial for different 
types of cells (Chevallay & Herbage, 2000; Julie Glowacki & Mizuno, 2008; Parenteau-
Bareil, Gauvin, & Berthod, 2010).  
Chondrogenic potential of bovine CMD scaffolds was also studied through 
quantification of their sulphated glycosaminoglycan content and also the expression of 
chondrogenic genes at sequential time points. Our findings showed that primary human 
dermal fibroblast cells are capable of GAGs production provided that they are placed in 
a proper chondrogenic environment.  
Upregulation of cartilage tissue specific genes like collagen type II, aggrecan, SOX9 
and COMP confirmed the differentiation of dermal fibroblasts to chondrocytes under 
proper chondrogenic 3D culture conditions. Some of the signalling mechanisms 
involved in chondrogenesis have already been described. It has been reported that Sox9 
is one of the earliest markers expressed in the mesenchymal condensations (Véronique 
Lefebvre, Li, & de Crombrugghe, 1998).As a key transcription factor in 
chondrogenesis, Sox9 is known for its role in activation of the expression of several 
cartilage-specific genes, including Col2a1, ACAN and COMP (Taipaleenmäki, 
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2010).During chondrogenesis, the expression of SOX-9 is up-regulated by TGF-β 
signalling (Shanmugarajan, Kim, Lee, & Im, 2011). 
We showed that scaffold shrinkage have inconsistent effects on cell chondrogenesis. 
Our findings revealed two distinct phases during the 6-week culture period. The 
simultaneous cell proliferations and scaffold shrinkage during the proliferation phase 
speeds up and facilitates the cell condensation which has been reported to be critically 
essential for chondrogenesis (Kavalkovich, 2000). This phase was synchronous with 
sharp increases in SOX9 gene expression as a chondrogenesis enhancer (Ng et al., 1997; 
Wright et al., 1995; Zhao et al., 1997). This suggests that the cell condensation at least 
partly triggers the up-regulation of the SOX9 expression which in turn activates the 
expression of COMP, COL2A1 and ACAN. 
The second phase starts at the peak point of cell proliferation and scaffold shrinkage 
with a suspension in cell proliferation, increases in expression of Col2A1 and ACAN 
genes as major chondrogenic differentiation markers. The biphasic trend suggests the 
presence of a critical state of cell density and cell-scaffold interaction in which the 
chondrogenic mechanisms are triggered.  This compulsory critical state was shown to 
be achievable partially through scaffold shrinkage which has so far been thought to have 
only limitative effects on chondrogenesis.    
Although our previous results showed a higher degree of cross linkage and hence 
improved mechanical properties in UV treated compared to UVDHT treated CMD 
scaffolds, UVDHT group showed significantly higher levels of Col2A1 and ACAN 
genes expression. 
In conclusion, physically treated bovine articular cartilage matrix derived scaffolds are 
capable of inducing chondrogenic differentiation in human dermal fibroblasts. Although 
this chondroinductive effect can be traced back to SOX9 level, however the precise 
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mechanism/s through which the cartilage matrix up-regulates SOX9 expression remain 
to be explored in other studies. 
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CHAPTER 7: DISCUSSION AND CONCLUSION 
It has been shown that extracellular matrix derived scaffolds from different sources have 
the potential to promote cartilage regeneration using tissue engineering applications. 
The source of biomaterial, the method of fabrication and the efficacy of chondrogenic 
differentiation have always been the main concerns related to engineering cartilage 
tissue oriented matrix derived scaffolds. Apart from the abundance of the source and 
ease of harvesting, the fabrication method has always been a major concern to retrieve 
the maximal bioactive chondroinductive ingredients of CMD scaffolds. Moreover, 
matrix derived scaffolds have poor mechanical properties and therefore, non-invasive 
treatments are necessary to increase their cross-linking and enhance the physical and 
structural properties of such scaffolds. The development of cartilage matrix derived 
scaffolds that possess suitable mechanical properties and chondroinductive abilities 
provide substantial advantage to the efforts of cartilage tissue engineering. Hence, the 
studies in this thesis were conducted to assess the chondroinductive potential of 
architecturally optimized CMD scaffolds. 
The first aim of the current study was to fabricate optimized CMD scaffolds by 
conducting a quantitative assessment of the changes in the architectural and the 
mechanical properties of physically cross-linked CMD scaffolds. We have reported the 
detailed processes of fabrication, physical treatment and methods of optimization of 
CMD scaffolds with bovine origin(Moradi, Pramanik, Ataollahi, Abdul-Khalil, et al., 
2014). A simple, restorative and non-invasive method of freeze-drying was used to 
fabricate scaffolds with different concentrations of CMD material. The scaffolds were 
treated with one of the five conditions to create cross-linking (Non-treated, UV, DHT, 
UVDHT, and DHTUV). In order to optimize the scaffold architecture, physical 
characterization was performed using FTIR, TGA, DSC, FESEM, porosimetry, 
mechanical tests and post-treatment shrinkage measurement.   
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A simple, highly accurate and precise method was developed to measure the porosity of 
highly porous ultra-light materials such as the CMD scaffolds in one of our 
experiments. We demonstrated that at15% concentration of cartilage matrix material, 
the fabrication of CMD porous scaffolds was optimal, beyond which the architecture of 
the scaffolds can drastically change to become unfavourable. We also demonstrated that 
UV and UVDHT treatment of 15% CMD scaffolds yielded optimized and properly 
tailored scaffolds for cartilage tissue engineering applications. 
The isolation, culture and characterization of primary human dermal fibroblast cells 
were discussed in chapter five. The cells were later used to assess the chondroinductive 
potential of UV and UVDHT treated 15% CMD scaffolds. Seeding the HDF cells on 
UV and UVDHT treated 15% bovine CMD scaffolds demonstrated that the materials 
were biocompatible constructs that allow HDF cells to attach, proliferate and produce 
cartilage matrix proteins e.g. GAGs. In addition, this results in the triggering of the 
mechanisms that upregulate the expression of cartilage specific genes including 
collagen type II, Aggrecan, SOX9, and COMP. 
Although UV and UVDHT treated 15% CMD scaffolds have demonstrated higher 
mechanical properties, the3D culture of primary HDF cells on these scaffolds led to 
substantial shrinkage, part of which was found to be due to cell mediated contractions. 
Of interest was also the fact that we demonstrated a biphasic process of proliferation-
chondroinduction during the cell culture. The synchronous trend of cell proliferation 
with the shrinkage of constructs clearly revealed that the cessation and subsequent drop 
in cell proliferation was a consequence of the reduction in construct size. While scaffold 
shrinkage has been reported to have inhibitory effects on chondrogenesis, our findings 
revealed that it may have contradictory effects. The initial period of upward slope in cell 
proliferation provided a high-density population of cells, resulting in a higher magnitude 
of cell-mediated contraction of the scaffold.  These augmented cell condensations 
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appeared to have ambivalent effects on chondrogenesis: preventing the cells to deposit 
more extracellular matrix due to the space scarcity, and simultaneous up-regulation of 
SOX9 gene expression; resulting in an increased expression of COMP, COL2A1 and 
ACAN as cartilage specific genes. Upregulation of SOX9 gene during the cell 
condensation phase resulting in an increased expression of COL2A1 and ACAN genes 
during the chondroinductive phase suggest that TGFβ signalling pathway might be 
involved in the chondroinduction of HDF cells using CMD scaffolds.  
In conclusion, the present thesis suggests that bovine articular CMD porous scaffolds 
have the potential to induce chondrogenic differentiation in human dermal fibroblasts, 
thus making it a potential biomaterial with likely future clinical applications. However, 
the present thesis lacks study that identifies the precise underlying mechanisms of which 
chondroinduction by CMD scaffolds was controlled. Hence, this remains to be studied 
in future studies. Of note, although scaffold shrinkage has an opposite effect on the 
chondrogenic properties of CMD scaffolds, improving the mechanical properties of 
CMD scaffolds may minimize the shrinkage and increase matrix deposition. This too 
will need to be looked at more deeply in future research undertakings. 
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